ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[ATF2, STARD13, SPARC, ROCK2, SERPINF1, PDE3B, SARS, VASH1, THBS1, MECP2, CXCL10, SPRED1, TBXA2R, NF1, CTNNB1, GHRL, TEK, HOXA5, GTF2I, CCR2]
GO:0060486;Clara cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;47.34738732320508;8.390779266560578;0.001584674443825551;0.7522251544931926;[NFIB, RBPJ]
GO:1990090;cellular response to nerve growth factor stimulus;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;97.48528473772916;5.9928839937622085;0.003262744749111514;0.6295966787287501;[USP8, APP, RAP1A, EIF4A3, RAB35, RAPGEF1, PTEN, CDC5L, CIB1, BPTF]
GO:0034198;cellular response to amino acid starvation;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;115.90251486529202;5.970411137910149;0.003879152867050031;0.6562464685024372;[BECN1, CDKN1A, SEH1L, MAP1LC3A, EIF2AK3, EIF2S1, SLC38A2, MAP3K5, ATF4]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[APP, EDA, TNFSF14, SPHK1, ZFP91, TNFRSF10B, TNFRSF10A, AGER, RELA, RC3H2, EGFR, NLRP12, IL23A, TRAF6, TLR7, CCL19, SASH1, LIMS1, HAVCR2]
GO:0008344;adult locomotory behavior;3.0;0.8436909121759173;0.6199657686781032;9.158520623246385;24.575257889458463;5.459585514144159;8.225117652639858E-4;0.47732376968016754;[NR4A2, MECP2, CSTB, APP, CHD7, PBX3, CTNS, PARK7, ARRB2, NTSR1, PAFAH1B1, ARCN1]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[ATF2, APP, CRTC2, CD40, EDA, TRADD, ITGB2, PTEN, CIB1, PARK7, RPS6KA4, RPS6KA5, EP300, TRIM27, IL10, PRKCI, CAMK1D, RIPK3, RIPK2, BUD31, SPHK1, IRAK4, TMEM173, PPRC1, MID2, TRAF6, KIT, CAT, TRIM14, PRKD2, ARHGEF5, CARD11, S100A8, RNF31, MTPN, CEBPG, NLRC4, LRP8, AGER, RELA, STK3, MTDH, NLRP3, RIPK1, CYTL1, PPARGC1B, FZD1, UBE2I, JUP, TAF12, NFKB1, NFKB2, IL6, FER, COPS5, CTNNB1, KRAS, TRIM32]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[RNF31, MTPN, APP, CD40, EDA, TRADD, ITGB2, CIB1, NLRC4, AGER, RELA, MTDH, RPS6KA4, RPS6KA5, NLRP3, RIPK1, PRKCI, RIPK3, RIPK2, SPHK1, IRAK4, NFKB1, MID2, NFKB2, FER, TRAF6, CAT, TRIM14, KRAS, PRKD2, TRIM32, CARD11, S100A8]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[ITGB1, CD40, BTG1, PDCD6, ITGB2, CIB1, BRCA1, PIK3C2A, THBS1, MTDH, AQP1, C3, RRAS, TBXA2R, ZC3H12A, ABL1, CTSH, PTK2B, SASH1, IL10, MAP3K3, XBP1, ANXA1, JUP, NOS3, SPHK1, PRKCA, SIRT1, RHOB, RUNX1, PDCL3, SFRP2, SP1, RLN2, AGGF1, GHRL, PRKD2, TEK, EPHA1]
GO:0003333;amino acid transmembrane transport;9.0;0.5756379274792419;0.68405958891991;8.302854513188667;195.84914281057607;5.500407508664414;0.006554894557084751;0.6775317209684948;[SLC36A1, SLC6A12, SLC1A4, SLC25A38, SLC25A29, SLC6A9, ARL6IP5, SLC38A6, SLC36A4, SLC25A22, SLC38A2, NTSR1, SLC25A13]
GO:0051884;regulation of timing of anagen;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;56.45327852205534;8.16763571524637;0.0018894404274810398;0.7686126355688037;[CTNNB1]
GO:0032328;alanine transport;10.0;0.8436909121759173;0.837086467948879;9.4949928598676;85.82177420350179;7.474488534686424;0.0028723775480089153;0.7974867031240476;[SLC36A1, SLC1A4, SLC36A4, SLC38A2]
GO:0030826;regulation of cGMP biosynthetic process;10.0;0.8259837884571596;0.8282329060895002;9.537552474286395;731.7084553858772;6.686031174322154;0.02448962350690857;0.7571649570480019;[NOS3, PTK2B, ADNP]
GO:0048489;synaptic vesicle transport;7.0;0.7671156992804218;0.7344772148974115;9.292052015870908;108.01043080855717;5.459585514144159;0.003615011916085639;0.6301228223472235;[TOR1A, SYT15, SYTL4, SYTL3, DNM2, RPH3A, P2RX7, AP3M2, AP3M1, TRIM9, SYNJ1, CDK5, BLOC1S1, OTOF, CTNNB1, AP3S2, SPG11]
GO:0071498;cellular response to fluid shear stress;4.0;0.7980440201809971;0.6490220100904985;9.271849308553389;39.92524609926753;6.8867018697843045;0.0013362620565537933;0.6021862538851576;[HDAC3, MAPK7, PTK2B, PKD2, SOCS5]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ITGB1, ELL, CHD7, ACVR1B, RIC8A, FLCN, CCNB1, FUT8, RXRA, SIN3A, SOX8, MGAT1, MSX1, ATP7A, SOX6, MYH10, GABPA, WDTC1, SLC39A3, MBNL1, ENDOG, UBE2B, ANGPT1, NOS3, ADAM10, TGFBR1, MIB1, BMP2, ALS2, MAFF, MYH9, CTNNB1, CCM2, EIF4E2, APBA3, SEC24C, APBA2]
GO:0010656;negative regulation of muscle cell apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.485423408851448;104.61422944852276;6.250713103064308;0.003501344112948074;0.6946617587785947;[SFRP2, BAG3, ZC3H12A, SIRT4, PTK2B, ALOX12, ARRB2]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[APP, PIGT, DIABLO, MAX, PSEN1, CIT, POLB, CDK5, AIFM1, CASP3, AKT2, BAX, BID, GAPDH]
GO:0030148;sphingolipid biosynthetic process;7.0;0.6913464685778243;0.6965925995461126;8.992535485772125;238.8284648682076;5.288437257948329;0.007993373787475071;0.6213702925661609;[ST6GALNAC1, ELOVL5, SPHK2, AGK, SPHK1, B3GALT4, ELOVL6, SGPP2, ALDH3A2, P2RX7, UGT8, SGPL1, COL4A3BP, SMPD4, VAPA, PRKD3, ALDH3B1, SMPD1, PEMT, DEGS1, PRKD2, B4GALT6, CSNK1G2, ST6GALNAC6]
GO:0070602;regulation of centromeric sister chromatid cohesion;9.0;0.811012628672052;0.801746939516315;9.34084218004034;56.72753252279278;8.390779266560578;0.0018986194620731454;0.8253454670833372;[CTNNB1]
GO:1902685;positive regulation of receptor localization to synapse;6.0;1.0;0.8231203125901445;9.628524252492122;27.088199349035225;9.777073627680469;9.066176544155354E-4;0.8231203125901445;[STX7]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[RAB3B, BCAR3, NCKAP1, CDKN1A, RTKN, GDI1, DOCK8, RAB3D, ITSN1, ARHGAP1, CHM, PARK7, ARHGAP6, RAPGEFL1, RAB43, DOCK11, RASGEF1A, GRAP2, ARHGDIB, CFL1, HRAS, RAB8A, RAB8B, RALGPS2, ARHGEF11, USP8, DBNL, KSR1, SH2D3A, SH2D3C, RHOH, RHOC, VAV1, VAV2, RHOB, NISCH, DOK2, ALS2, RAB36, CDC42EP4, RAB35, ELMO1, RAPGEF1, TAX1BP3, ARHGEF1, RAB38, RHOU, DOCK2, KPNB1, RAB5C, RGS19, ROCK2, SHC1, RAB1B, RAP1GDS1, WAS, RASGRP2, PLD1, RASGRP4, RASGRP3, RAB21, RAP1B, ABR, RHOT2, PAK1, NRAS, RHOT1, RAB20, RAP1A, RRAS, RAB40C, RAB28, RAB6A, RALGDS, RAB4B, SETDB1, RAB27B, MYO9B, RFXANK, DHCR24, RAB11A, COL1A2, ARHGAP30, RAB15, RAB13, CDK2, RAB18, NF1, KRAS, RGL1]
GO:1904861;excitatory synapse assembly;5.0;1.0;0.7902410118609202;9.628524252492122;37.238733880868345;8.16763571524637;0.0012463469103079984;0.7079342821725234;[NPTN]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[NAPA, PTEN, SLC1A4, GLS, ATXN3, GRM2, HRH2, KCNMB1, CHRNA10, MBP, NPTX1, SNCB, SPG11, NTSR1, NQO1, CHRNB3, HTR3B, SSH1, ALS2, SYPL1, CDK5, ADORA2A, PNOC, VDAC3, EXOC4, UTS2, CTNNB1, AMPH, PDE7B, APBA3, APBA2, KCNK3, PAFAH1B1, GPR19]
GO:0046620;regulation of organ growth;5.0;0.6954798709641801;0.6379809473430103;8.741221057491218;36.77819272999274;5.334422371190153;0.0012309330124483187;0.5630436199995941;[G6PD, PARP2, PTEN, STK4, RBPJ, TGFBR1, STK3, SOD1, CCNB1, MEIS1, PAK1, LATS2, WWC3, JARID2]
GO:0003340;negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;8.0;1.0;0.875;9.628524252492122;683.3567818519086;8.67846133901236;0.022871336507407674;0.8188169164668168;[CTNNB1]
GO:1904501;positive regulation of chromatin-mediated maintenance of transcription;11.0;1.0;0.9324289523296623;9.628524252492122;1604.3463414477296;9.777073627680469;0.05369602823028881;0.9324289523296623;[CTNNB1]
GO:0021540;corpus callosum morphogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;69.80210411808247;8.16763571524637;0.002336213607016992;0.8501222226412654;[C12orf57, ZEB2, PAFAH1B1]
GO:0042147;retrograde transport, endosome to Golgi;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;84.48667651462847;5.311165509025885;0.0028276930298722367;0.5947335637161829;[TMEM87A, VPS29, TMEM87B, MAGEL2, STX16, DCTN1, GOSR2, GOSR1, VPS26A, VPS26B, VPS53, VPS52, CLTCL1, VTI1A, STX5, VPS54, ANKFY1, AP1S1, TRIM27, RAB6A, TBC1D17, PLEKHJ1, ZFYVE21, BAIAP3, TBC1D23]
GO:0061324;canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;199.46772235796817;9.777073627680469;0.006676005158025803;0.9152410118609203;[CTNNB1]
GO:0003222;ventricular trabecula myocardium morphogenesis;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;28.30750056401912;7.004484905440688;9.474265687811956E-4;0.7091290490632969;[CHD7, RBPJ, TGFBR1]
GO:0060479;lung cell differentiation;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;21.066225782797595;6.7325511899570465;7.050676185779127E-4;0.594302980950052;[THRB, THRA, NFIB, CTNNB1, RBPJ, HOXA5]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP2, NCKAP1, BMPR2, NCF1, ROCK2, NCF2, ITGB3, PDCD6, VAV1, VAV2, AXL, ELMO1, PTK2B, NCKAP1L, ITGAV, PRKD2]
GO:2000008;regulation of protein localization to cell surface;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;29.0551629072873;6.166155715036245;9.724501545579579E-4;0.6384578026126634;[FCER1G, TOR1A, BDNF, EGF, CTNNB1, TAX1BP3, LRIG2, COMMD1, ABCA12, TM9SF4, PICALM, RAB11FIP5]
GO:0001711;endodermal cell fate commitment;5.0;1.0;0.7902410118609202;9.628524252492122;21.33815949828185;7.9853141584524145;7.141689953107157E-4;0.6986103492792611;[CTNNB1, RTF1]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[JUP, SDC4, PLEKHA2, CIB1, SFRP1, CDK6, ABL1, DAG1, PTK2B, TEK, EPHA1, UTRN, CCL28, LIMS1, S100A10]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[ERRFI1, APP, BMPR2, SPARC, MCM7, EIF4A3, PTEN, CIB1, NR3C1, HYAL2, STK16, CPNE3, ATP7A, SOX6, EMD, PDE8A, PDGFRB, IL10, USP8, ANXA1, CAD, RUNX2, SIRT2, TGFBR1, ERN1, SFRP1, RAB35, CAT, RAPGEF1, MT1G, PRKD2, BECN1, SHC1, TWF2, LRP8, THBS1, RELA, EGFR, CLEC3B, BAG4, RAP1A, MAPK7, CCL5, CCL2, RIPK1, BPTF, TBX1, WNT10A, CAV1, CDC5L, PTPN12, BMP6, SMAD7, SETX, VIL1, BMP2, EHD4, MARS, MDM2, CTNNB1, LIMS1]
GO:0070830;bicellular tight junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;6.280566066213989;0.001878987018571015;0.6443087532925187;[PRKCI, PDCD6IP, PARD6A, RAB13, ARL2, ECT2, MPP7, MTDH]
GO:0001837;epithelial to mesenchymal transition;5.0;0.7508913569872202;0.6656866903545304;8.647694999480395;23.145667324477426;5.618190544320798;7.746646556020492E-4;0.5775555375700647;[DDX17, PDCD6, NOLC1, KLHL12, RBPJ, TGFBR1, RTN4, OLFM1, BMP2, ADAM15, CTNNB1, SPRY1, MSX1, FAM83D, KBTBD8]
GO:0048250;iron import into the mitochondrion;10.0;1.0;0.9152410118609203;9.628524252492122;155.42349744911857;9.083926447120524;0.0052018845875555575;0.8797934328124444;[SLC25A28]
GO:2000249;regulation of actin cytoskeleton reorganization;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;36.19570401534177;6.221725566191056;0.0012114376393747596;0.6931793347948383;[CDK5, FES, ARHGDIB, ABL1, PTK2B, TEK, HRAS]
GO:1900272;negative regulation of long-term synaptic potentiation;9.0;1.0;0.896240625180289;9.628524252492122;54.24497338163739;7.57984905034425;0.0018155304417768478;0.7838744581139225;[PRNP, APP, ABL1, AGER]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[P2RX4, ITGB2, PTK2B, PTX3, PKD2, DNM2]
GO:0031460;glycine betaine transport;9.0;1.0;0.896240625180289;9.628524252492122;100.7816381261037;9.777073627680469;0.0033730707304949633;0.896240625180289;[SLC38A2]
GO:1900273;positive regulation of long-term synaptic potentiation;9.0;1.0;0.896240625180289;9.628524252492122;146.46287151967024;6.832634648514029;0.004901980501736697;0.7456618788553018;[APP, ADORA2A, STAU1, NPTN, NRGN]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[SCARB1, CETP, APP, INSIG1, HDLBP, PCSK9, EBP, NSDHL, RXRA, CYB5R3, FDXR, SCAP, APOL1, SCARF1, LBR, APOL2, HSD3B7, STARD3, MBTPS1, FDPS, G6PD, GGPS1, CNBP, DHCR24, ERLIN2, CEL, TRERF1, ACLY, SQLE, SOAT1, SNX17, CAT, NFE2L1, PPARD]
GO:0045665;negative regulation of neuron differentiation;8.0;0.6162540371078848;0.6831270185539424;8.732436227935485;338.1488864638422;4.401795219996305;0.011317538915704735;0.6001080122550225;[NLGN3, DDX6, APP, SEMA3C, LRP1, GDI1, FOXG1, GFI1, PTEN, ID2B, CIB1, RNF6, PSEN1, RTN4, EIF4ENIF1, SOX8, LRIG2, B2M, ZNF365, SEMA6B, MYLIP, JAG1, SEMA4D, SEMA4B, PAQR3, OMG, THOC2, MIB1, GAK, DNM3, MEIS1, CDK5, CTDSP1, RUFY3, GORASP1, MDM2, ULK2, FKBP4, FGF13, PAFAH1B1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, RNF31, CD40, EDA, SLC20A1, TRADD, SECTM1, CXXC5, RELA, MTDH, AKAP13, CASP8, TFG, CASP10, UBD, NUP62, ABL1, RIPK1, CCL19, PIM2, ECT2, IKBKE, APOL3, TMED4, MAP3K3, CD74, UBE2I, RIPK2, PRKCE, NEK6, ZDHHC13, TNFRSF10B, IRAK4, RHOC, ZDHHC17, MID2, CD4, VAPA, TNIP2, TRAF6, CTNNB1, LTBR, TRIM32, CARD11, BIRC3]
GO:0046513;ceramide biosynthetic process;8.0;0.811012628672052;0.780506314336026;9.474373572664863;443.75121156962103;6.015873511986907;0.014851953701072812;0.6826520511697386;[P2RX7, UGT8, ST6GALNAC1, SMPD4, AGK, SMPD1, B3GALT4, DEGS1, B4GALT6, ST6GALNAC6]
GO:0044334;canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition;9.0;1.0;0.896240625180289;9.628524252492122;34.305501416841174;9.083926447120524;0.0011481742594748403;0.8607930461318132;[TCF7L2, CTNNB1]
GO:0043248;proteasome assembly;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;44.51706700895919;7.138016298065211;0.0014899461700306506;0.6881587980249038;[PSMD8, PSMD11, PSMD4, PSMD13, POMP]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[IL6, BMP2, BMPR2, SFRP2, JAG1, TMEM119, FAM20C, CTNNB1, RUNX2, BMP6]
GO:0044336;canonical Wnt signaling pathway involved in negative regulation of apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;34.305501416841174;8.390779266560578;0.0011481742594748403;0.8253454670833372;[TCF7, CTNNB1, MITF]
GO:1990791;dorsal root ganglion development;5.0;1.0;0.7902410118609202;9.628524252492122;31.419853007278505;9.083926447120524;0.0010515942041217404;0.7547934328124444;[CTNNB1]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[SERPINA3, APP, SPARC, WDR1, ITGB3, PROS1, ITGA2B, ENDOD1, F13A1, THBS1, CYB5R1, CLEC3B, ISLR, TMSB4X, LAMP2, CDC37L1, PHACTR2, FAM3C, TIMP1, A2M, FGA, VWF, APOOL, BRPF3, EGF, FGG, RAB27B, PPBP, SYTL4, TUBA4A, SOD1, SELP, F8, MMRN1, CD9, SERPING1, MAGED2, NHLRC2, CALM1, ALDOA, TLN1]
GO:0048023;positive regulation of melanin biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;326.1157545976263;8.390779266560578;0.010914800821258081;0.7800242071602487;[ZEB2]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[OXTR, YWHAB, IL5RA, SPRED1, RASGEF1A, MYC, CTSH, ITGAV, MAP3K9, HRAS, JAK3, MAP3K5, PDGFRB, DUSP5, MAP4K2, KSR1, FBXW11, SH2D3A, RIPK2, PAQR3, SH2D3C, IRAK4, GFRA2, SPTB, ITPKB, KARS, TRAF6, KIT, MET, HBEGF, ARHGEF6, PTGER4, CAMK2D, SHC1, GPS1, GPS2, IL2RG, RASGRP4, EGFR, RASGRP3, NRAS, MAPK7, PABPN1, CCL5, CCL3, CCL2, PTK2B, NCAM1, MBP, RIPK1, SULT1A3, MAP4K3, SPTBN1, MAP3K3, MAP3K1, ANGPT1, EGF, NFKB1, MAPK13, SETX, STK24, PTPRA, TNIP2, IL2RA, TAOK2, NF1, CCM2, KRAS, TEK, CALM1, FGF13, MAP3K11]
GO:0006814;sodium ion transport;7.0;0.811012628672052;0.7564256795932265;9.310070521373587;34.16983994150393;4.629579150867016;0.001143633791982704;0.5876762583299873;[SLC12A2, SLC23A2, SLC24A3, SLC20A2, SLC20A1, SLC10A2, COMMD3, SLC6A12, PKD2L1, ATP1B2, ATP1A1, PKD2, SLC5A6, SLC8A3, COMMD9, SLC9A6, SLC6A9, SLC9A8, SCNN1A, SLC38A6, MAGED2, FGF13, SLC38A2, TRPM4]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[ITGB1, LAMA5, ITGB5, ITGB4, ITGB3, ITGB2, ITGA2B, NEDD9, ITGAE, FUT8, ADAMTS1, ABL1, ITGAX, PTK2B, ITGAV, FCER1G, SYK, ITGA2, RCC2, ITGA1, ADAM10, VAV1, ITGAD, ADAM15, MYH9, CCM2, TLN1]
GO:0010758;regulation of macrophage chemotaxis;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;137.30556446799892;6.686031174322154;0.004595493675758551;0.7381645703673706;[KARS, CCL5, PTK2B, THBS1]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[BATF2, IRF4, CAMK4, UBD, TRAF6, LTBR, PSEN1, RBPJ]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[CD86, IFITM3, CD80, PITPNA, MPL, IL5RA, F13A1, CIB1, RORA, IFIT1, IFIT3, RPS6KA4, RPS6KA5, MYC, CFL1, IL12A, B2M, IFNAR2, IL15RA, HLA-H, IL4R, RSAD2, FBXW11, PRKCD, FLT3LG, HLA-C, TALDO1, HLA-A, HLA-F, KARS, IL23A, BOLA2, FSCN1, PSME2, STX1A, CCL3L1, SHC1, EBI3, ADIPOR2, IL22RA2, HSP90B1, RAP1B, SOCS2, BAG4, NDN, RIPK1, CD300LF, HLA-DQA1, CCR10, SOCS4, SOCS5, BBS2, HLA-DRB4, TNFSF14, TNFRSF10B, MSN, TNFRSF10A, ISG15, PPBP, NFKB1, NFKBIA, CXCL10, IL6, CXCL11, FER, COL1A2, TNFSF4, SDC1, HLA-DRA, HLA-DRB3, BRWD1, IL7R, XAF1, ITGB1, CXCL6, CIITA, CDKN1A, CD40, CXCL9, EDA, TRADD, ITGB2, IL27, TNFRSF13C, CXCL5, OASL, CASP3, TMSB4X, CCR9, ITGAX, TIMP1, JAK3, CCR4, PF4V1, CCR2, HLA-DPA1, IL10, MKKS, ANXA1, TNFRSF12A, SYK, GPR35, RIPK2, IL15, IRAK4, TYK2, GAB2, YWHAZ, SIRT1, VAV1, OAS1, IRF4, OAS2, OAS3, TRAF6, KIT, RAPGEF1, RHOU, LCP1, HLA-DQB1, BIRC3, LAMA5, CAMK2D, IFI6, IL2RG, SAMHD1, LRP8, RELA, CCL5, IL21R, CCL3, STAT4, CCL2, PTK2B, NCAM1, CCL19, IL12RB1, RELT, SH2B2, MAP3K3, CD74, CCL20, CD70, BAD, MX2, MX1, SOD1, POMC, CD4, KLF6, TNIP2, IL2RA, CLCF1, HLA-DPB1, KRAS, PTPN6, LTBR, PLP2, LIMS1]
GO:0043252;sodium-independent organic anion transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.444869117505266;0.0010672445075450394;0.6805102716434839;[SLCO3A1, SLCO1A2]
GO:0045671;negative regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;842.5336305879634;6.481236761676141;0.028198842384740134;0.7276913745807394;[SFRP1, FBXW7, GPR55, CCL3, NF1, CTNNB1, LILRB3, TOB2]
GO:0016197;endosomal transport;5.0;0.7090535922965819;0.6447678080092112;8.817594036275793;47.18803257139101;4.463867648638682;0.0015793409836922997;0.5185234110033771;[TMEM87A, VPS29, TMEM87B, MAGEL2, STX16, DCTN1, VPS4B, DENND1A, GOSR2, GOSR1, CLEC16A, ARHGAP1, WAS, VPS26A, VPS26B, LYST, BLOC1S1, VPS53, VPS52, CLTCL1, VTI1A, STX5, VPS54, ANKFY1, AP1S1, TRIM27, RAB6A, TBC1D17, VPS16, PLEKHJ1, GRIPAP1, ZFYVE21, VPS37A, VPS37B, RAB11A, BAIAP3, EHD4, ALS2, SNX17, RAB13, RAB35, CHMP4B, UBAP1, TBC1D23, CHMP6, PICALM]
GO:2000138;positive regulation of cell proliferation involved in heart morphogenesis;8.0;0.8653626801206646;0.8076813400603323;9.466005322994347;169.01630970402968;7.9853141584524145;0.0056568237809906195;0.7833693374183408;[RBPJ]
GO:2000017;positive regulation of determination of dorsal identity;6.0;1.0;0.8231203125901445;9.628524252492122;84.15966440839325;9.083926447120524;0.0028167482289683326;0.7876727335416686;[CTNNB1]
GO:0010752;regulation of cGMP-mediated signaling;7.0;0.8653626801206646;0.7836007053175329;9.34084218004034;45.070113835906206;9.083926447120524;0.001508456149618737;0.8154717862087246;[PTK2B, THBS1]
GO:0031334;positive regulation of protein complex assembly;6.0;0.612588685250814;0.6294146552155515;8.094593892566166;105.21570715161425;4.251620688548686;0.0035214750303757575;0.5405483923231058;[HRK, NCKAP1, NUMA1, WIPF2, ARPC1A, WASL, MECP2, TRIM27, ACTR2, TIGD5, PRKCE, MITF, RHOC, DDB1, CLIP1, PSRC1, CTTN, CDC42EP4, FSCN1, LCP1, MAPRE1, MET, ARHGEF5, PFN2, MAGEL2, PAXIP1, DCTN1, WAS, XPA, ARL2, IQGAP2, ACTR3B, BCLAF1, BAG4, PAK1, PTK2B, NCKAP1L, BID, CLASP1, VASP, GSN, BIK, NR1H2, MSN, ARPC4, GTF2H4, MPP7, SETX, VIL1, CNOT6, FER, PAN3, ARPC2, CNOT1, FES, PSMC1, ERCC1, BAX, CTNNB1, ERCC5]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[RIPK3, FZD5, NKAP, CTNNB1, B2M]
GO:0060492;lung induction;8.0;1.0;0.875;9.628524252492122;376.26422697189867;8.67846133901236;0.012593225060929974;0.8188169164668168;[CTNNB1]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[PRNP, APP, CDK5, LRP1, PSEN1, FCGR2B, AGER, IGF1R]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[FER, SYK, FES, GRAP2, ABL1, PTK2B, CSK, TYK2, JAK3, EGFR, IGF1R]
GO:0048821;erythrocyte development;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;33.53950096943652;6.832634648514029;0.0011225369138558525;0.639662265535933;[TMOD3, ARID4A, NCKAP1L, BPGM, SOX6]
GO:0048820;hair follicle maturation;4.0;1.0;0.75;9.628524252492122;22.57030317957519;7.8311634786251565;7.554077354662837E-4;0.6504860644832351;[NF1, RBPJ, TRPC4AP]
GO:1904886;beta-catenin destruction complex disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;38.04764185170599;6.7325511899570465;0.0012734203321220245;0.6345439928109722;[FZD1, FZD5, CAV1, DVL3, CTNNB1, PPP1CA]
GO:0007007;inner mitochondrial membrane organization;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;40.89124569080843;6.039404009397101;0.0013685931935394774;0.6319757144917204;[APOO, APOOL, AGK, TMEM11, CHCHD6, ATP5J, ATP5I, ATP5O, ATP5F1, TAZ, ATP5L]
GO:0030239;myofibril assembly;7.0;0.8436909121759173;0.7727648213451592;9.446202695698167;124.77085412528295;6.166155715036245;0.004175968201094763;0.6662568552797195;[PDGFRB, TMOD3, MYH10]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[PTGER4, MTPN, CD40, MAP3K1, TNFSF14, BAD, ITGA2, TNFRSF10B, TNFRSF10A, ATP1A1, NFKB1, BMP6, EGFR, AQP1, CASP8, BAG3, NPPA, DAG1, CASP2, TLR8, TLR7, LTBR, SLC38A2]
GO:0048278;vesicle docking;5.0;0.811012628672052;0.6957473261969462;9.176539128749065;21.38880323109876;5.618190544320798;7.158639954716971E-4;0.5775555375700647;[RAB3B, VPS18, STX17, CAV2, STX16, VPS33A, RAB3D, VPS33B, STX7, RABEPK, STX11, RAB15, VPS11, EXOC4, STX5, VPS45, RAB8A, STX1A, RAB8B]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[ITGB1, CXCL6, CXCL9, WDR1, DOCK8, ITGB3, PROS1, ITGB2, SIRPG, LYST, PIK3CG, CXCL5, PREX1, ITGAX, ITGAV, PF4V1, CCR2, IL10, FCER1G, ANXA1, SYK, ITGA1, ATP1B2, IRAK4, VAV1, DOK2, KIT, MYH9, ARHGEF5, S100A8, GYPA, CCL3L1, SDC4, SHC1, SDC2, CD99L2, CORO1A, GLG1, CNR2, CCL5, CCL3, CCL2, NCKAP1L, CCL19, JAM3, TRPM4, HSD3B7, CD74, PPIL2, GPR15, ANGPT1, CCL20, CAV1, TNFRSF10B, MSN, TNFRSF10A, PPBP, GP6, SELP, CXCL10, NLRP12, IL6, CXCL11, FER, COL1A2, SDC1, PTPN6, TEK, CD244, MYO1G]
GO:2000144;positive regulation of DNA-templated transcription, initiation;11.0;0.8933024483968273;0.8790801765280758;9.604426700913061;1600.8530134724567;6.444869117505266;0.05357910968674749;0.7620198587159455;[SETX, BCLAF1, PAXIP1, PSMC1, CTNNB1, MITF]
GO:0030111;regulation of Wnt signaling pathway;6.0;0.5902001590945054;0.6182203921373972;7.99439372746765;41.8512380110395;4.069963362931594;0.0014007232725606145;0.5312584282431182;[APP, EDA, CHD8, USP34, LRRK1, TNFAIP3, RBPJ, MED12, CDH2, SPIN1, EMD, DACT1, TLE4, USP8, CSNK2A1, TSC2, SENP2, RUNX1, AES, DEPDC1B, SFRP1, ZEB2, SFRP2, LATS2, CCNY, TBL1XR1, RAPGEF1, TAX1BP3, NAIP, MACF1, LRP1, HDAC1, KLHL12, PRICKLE1, PSEN1, APCDD1, STK4, EGFR, ARNTL, STK3, PPP2CA, RNF213, UBR5, ABL1, DVL3, DISC1, TRPM4, FZD1, TCF7L2, JUP, FZD5, EGF, CAV1, FZD6, NFATC1, NFKB1, PPP1CA, CYLD, BMP2, DAB2, GNAQ, MKS1, LGR4]
GO:2001234;negative regulation of apoptotic signaling pathway;8.0;0.6913464685778243;0.7206732342889122;9.146686165599384;292.02860154420875;4.420487353008457;0.00977393448500626;0.601063928806537;[TRADD, TNFAIP3, BRCA1, PARK7, ARRB2, ING2, CASP8, ITGAV, FGA, DAPK1, FGG, PLAUR, SIRT1, TGFBR1, MAPK8IP1, CREB3, SFRP2, CTTN, TMBIM1, PPIF, VDAC2, BIRC6, RNF34, IFI6, PSEN1, THBS1, RELA, BCL2L12, MNT, HSPH1, MAPK7, FIGNL1, LMNA, RIPK1, RFFL, BID, CDKN2D, IVNS1ABP, TCF7L2, CD74, PRELID1, XBP1, EYA2, WFS1, NOS3, NONO, SYVN1, TNFRSF10B, TNFRSF10A, NR4A2, QARS, MDM2, BAX, CTNNB1, HYOU1, TRIM32]
GO:0007172;signal complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;86.36830501999869;7.697632086000634;0.002890669442591265;0.7167775754447168;[PTK2B]
GO:0060441;epithelial tube branching involved in lung morphogenesis;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;53.5045405888233;7.004484905440688;0.0017907488225476112;0.7091290490632969;[DAG1, CTNNB1, KRAS, HOXA5]
GO:0070925;organelle assembly;4.0;0.6056485694559711;0.5528242847279856;7.5284634236095505;37.307726752352394;3.470798340732454;0.0012486560396270164;0.4274967885536867;[GALNT11, NCF1, BCCIP, FNBP1L, TUBB1, ZNF207, NEK1, FBXO5, PDGFRB, GABARAPL1, TMOD3, STX7, MYO7A, TBC1D20, TMEM138, RFX4, CHMP4B, ULK2, ULK1, RAB38, KPNB1, DDX6, TUBGCP2, PSEN1, CORO1A, SPATA6, ATXN2, KIF3B, MYH10, ATG5, BBS2, VTA1, NEK6, IFT122, EIF2S1, PUM2, VIL1, NSFL1C, CNOT7, CDK2, MKS1, LSM14A, ATG2B, SPAG16, TTC26, ONECUT2, NUMA1, PTEN, BICD1, MAP1LC3A, SH3PXD2A, C1QBP, NUP62, TMEM107, SH3PXD2B, IFT57, SNAP29, RAB8A, ACTR2, MKKS, PDCD6IP, DBNL, VPS37A, VPS37B, TUBG1, WDR34, DYNLL2, SEPT5, SEPT2, NCOR1, PIK3C3, MAPRE3, CHMP6, MAPRE1, MAPRE2, PAFAH1B1, C9orf72, BIRC3, BECN1, LAMA5, HDAC3, DCTN1, NIP7, VPS4B, SYNPO2, ABLIM3, TP53INP2, TP53INP1, UBQLN1, DISC1, CLASP1, DYNC1H1, SEPT11, GSN, RAB11A, P2RX7, CENPE, CENPF, CENPH, TTLL3, CENPJ, CENPK, CCDC65, CLUAP1]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[PPP1R15A, EIF5A, KHDRBS1, RPS9, CDC123, YTHDF3, POLDIP3, ITGA2, EIF4A3, SAMD4A, UPF3A, THBS1, FXR1, RBM3, IL6, RXRA, FXR2, C1QBP, CCL5, BCL3, RPS6KB2, PTK2B, POLR2G]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, SHC1, IL2RA, PTK2B, IL2RG, JAK3]
GO:0007176;regulation of epidermal growth factor-activated receptor activity;11.0;0.8653626801206646;0.8651102923899945;9.56398573135455;373.36400259879497;6.409777797693995;0.012496157161194671;0.7602252869888839;[ERRFI1, APP, NCF1, SHC1, EGF, FBXW7, PSEN1, CHMP6, ADRA2C, SOCS4, SOCS5]
GO:0061890;positive regulation of astrocyte activation;11.0;1.0;0.9324289523296623;9.628524252492122;597.8622644248292;8.67846133901236;0.020009911949193635;0.8762458687964789;[APP, AGER]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[ARF4, DGKD, CAMLG, SHC1, EGF, PIK3C2A, EGFR, VIL1, RPS6KA5, RASSF2, FES, ABL1, REPS2, PTK2B, FAM83A, HBEGF, SOCS5]
GO:0061419;positive regulation of transcription from RNA polymerase II promoter in response to hypoxia;13.0;1.0;0.9625549647676366;9.628524252492122;4007.3038921660486;8.16763571524637;0.13412085493143808;0.8802482350792397;[RBPJ]
GO:0009912;auditory receptor cell fate commitment;6.0;1.0;0.8231203125901445;9.628524252492122;45.87272196558231;8.67846133901236;0.0015353187214185752;0.7669372290569613;[RBPJ]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[VPS29, AHCYL1, RPL3, NUP107, ARL6IP1, ZDHHC6, IFIT1, PEX26, RPS15, AKT2, LONP2, AP1S1, ARFIP1, HOMER3, MLYCD, TBC1D22A, SIL1, GOLGA7, VPS18, GSTK1, ARL11, ACOT8, PRKCI, COG3, AP1B1, MYO7A, SYTL4, SYTL3, BCR, NUP93, ACOT2, RPL29, RPL28, ACOT4, STX1A, TBC1D9B, VPS26A, VPS26B, VPS11, VTI1A, SSR1, VPS16, SEC31A, CTSA, EGR2, PMM1, RAB3IP, PMM2, RAB27B, POLA2, NPLOC4, RPS27, HYOU1, CD24, ARF3, ARF4, TRAM1, SRP54, CLTA, CHM, XPO5, KIF13B, TMED2, TMED1, AP3S2, TMED7, RAB8A, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SYK, SSR2, SSR3, ZDHHC12, RHOB, CTTN, AGPS, EXOC4, SLU7, ARF5, NAPA, RABGAP1, TOMM40, STX17, STX16, ZDHHC23, HSD17B4, ZDHHC24, DERL2, PRICKLE1, TRAK1, RGPD1, NAPG, STX11, ARNTL, GGA3, ASNA1, LMNA, AP2S1, HEATR3, STX5, MFN2, BID, RAE1, RPL19, PEX16, CD74, PEX19, RANBP3, AGK, SYVN1, RAB11A, PEX14, ARCN1, DHRS4, SPCS2, SNX17, NEDD4, TAOK2, RAB3GAP2, COPG2, RAB3B, NCF1, PDCD6, RAB3D, UBE2D3, BCCIP, TBC1D3C, IPO7, IPO4, RAB43, RPH3A, IPO8, IPO9, LAMP2, KPNA4, KPNA5, RPS9, RPS7, STX7, TOMM34, TSC2, TBC1D2B, RPSA, CLIP1, RAB36, RAB35, CHMP4B, RAB38, SLC27A2, KPNB1, RTN2, COPB2, COPA, RAB5C, HSP90B1, NCKIPSD, CLTCL1, RAB6A, TBC1D17, TBC1D15, AP1M1, DNAJC19, RAB4B, IDH1, ASPSCR1, NUP153, TIMM44, NFKBIA, PAN3, AMACR, CDK5, BCL3, RTP4, YWHAB, SEC61A2, AP1G2, AP1G1, NUP62, TLK1, EVI5L, TNPO1, TNPO2, ARL5A, TNPO3, EIF5A, VPS13C, VPS13D, TBC1D8, PEX7, TBC1D3, ACOX2, ACOX1, PEX6, EHHADH, CAT, RPL37A, ACOX3, RAB1B, GOSR2, RAB21, AP3M2, AP3M1, RAB20, RAB40C, RAB28, TIMM8B, MBTPS1, RPL23A, GDAP1, RAB15, VPS41, RAB13, RAB18, RUNDC1, VPS45, SEC24C]
GO:0045603;positive regulation of endothelial cell differentiation;7.0;0.8436909121759173;0.7727648213451592;9.503361109538115;205.17606198895368;7.004484905440688;0.006867058148302753;0.7091290490632969;[CLDN5, BTG1, CTNNB1, BMP6]
GO:0003256;regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation;12.0;0.9326813400603323;0.9144609826203107;9.582004236857228;254.25611305023727;7.8311634786251565;0.008509723288145666;0.8486063770733797;[RBPJ]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ERRFI1, TBC1D3C, DOCK11, PREX1, RGS1, AKT2, ARHGDIB, TBC1D22A, TSC2, TBC1D2B, GAPVD1, BCR, TIAM2, DEPDC1B, SFRP1, TBC1D20, PKP4, RIN3, EPHA1, TBC1D9B, CCL3L1, RASGRP2, RASGRP3, RIC8A, ABR, ARHGAP21, RIC8B, RAP1A, DVL3, NCKAP1L, ECT2, A2M, TBC1D17, SRGAP2, SRGAP1, TBC1D15, S100A10, STARD13, CAV2, RCC2, ARHGAP26, ARHGAP25, ARHGAP30, GNAQ, NF1, GNB5, EZH2, PICALM, ITGB1, CD40, GDI1, DOCK8, DENND1A, ARHGAP1, CHM, ARRB1, ARHGAP6, EVI5L, HRAS, ARHGEF11, PLEKHG4, SEC13, TBC1D8, GMIP, VAV1, ARFGAP1, TBC1D3, ALS2, CDC42EP4, TBC1D7, DEPDC1, RAPGEF1, TAX1BP3, ARHGEF1, DOCK2, ARHGEF5, ARHGEF6, RABGAP1, RGS19, RAP1GDS1, CCL5, CHN2, CCL3, CCL2, PTK2B, CCL19, RANBP3, SEMA4D, CCL20, MYO9B, DLC1, RUNDC1, RAB3GAP2, AGRN, SMAP1, RAB3GAP1, LIMS1]
GO:0006637;acyl-CoA metabolic process;5.0;0.5902001590945054;0.5853410914081729;7.97986562690474;77.21017702370673;5.244474134527214;0.0025841551403354684;0.5584436629936305;[SLC25A1, ACOT9, ACOT8, ACOT7, ACSM3, ELOVL5, ACSL6, HSD17B4, ACSL5, ELOVL6, DBI, ACSL3, ACACA, ACLY, GPAM, DBT, ACOT2, OGDH, SUCLG1, ACSBG1, MLYCD, ACOT4]
GO:0030502;negative regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;172.15796001199809;6.943860283624253;0.005761971989496609;0.7060287030842711;[CCL3, PTK2B, TRPM4]
GO:0006878;cellular copper ion homeostasis;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;186.04478652569694;7.138016298065211;0.006226751575577643;0.7802794972956796;[PRNP, APP, SLC31A1, ATP7A]
GO:0042340;keratan sulfate catabolic process;8.0;1.0;0.875;9.628524252492122;411.1022627208988;7.292166977892469;0.013759222765252392;0.747921758369865;[GALNS]
GO:0035635;entry of bacterium into host cell;7.0;1.0;0.8509193652572005;9.628524252492122;28.374411874040543;7.697632086000634;9.496660301113433E-4;0.7445766281117727;[CTNNB1, MET, CBLL1]
GO:0098815;modulation of excitatory postsynaptic potential;7.0;0.7866048967936545;0.7442218136540277;9.392135474427892;100.6598909114356;6.139487467954083;0.0033689959607854014;0.6648930398837374;[NLGN3, APP, EIF4A3, PTEN, PTK2B, STX1A, SH3GL1, SSH1]
GO:0051968;positive regulation of synaptic transmission, glutamatergic;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;135.83014596643335;6.375876246018314;0.004546112746301595;0.701062607729944;[NLGN3, OXTR, ADORA2A, PTK2B, RAB3GAP1, EGFR]
GO:0051963;regulation of synapse assembly;6.0;0.7090535922965819;0.6776471087384355;9.0306872517365;59.898395703774696;5.322726331426962;0.002004745399149018;0.5953247847114072;[NLGN3, MECP2, OXTR, BDNF, GHRL, ADNP, PDLIM5, AGRN]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[APP, OXTR, AHCYL1, DGKD, DGKA, ITSN1, DEFB1, RAPGEFL1, GPR174, PREX1, GNAT2, RGS1, ADORA3, NPPA, HOMER3, PDE8A, PDGFRB, CD97, TIAM2, GPR162, SFRP1, SFRP2, PRKD3, SPNS1, UTS2, XPR1, ATF4, GNAZ, SUCNR1, CCL3L1, IQGAP2, CRHR1, RIC8A, C3, ABR, RIC8B, TBXA2R, HRH2, GRK6, ECT2, NTSR1, CCR10, SULT1A3, FZD1, OR2B2, GPR15, OPN3, FZD5, HOMER2, CAV1, FZD6, PPBP, OR52K2, GNG11, CXCL10, CXCL11, GPR180, GNAQ, GNB2, PNOC, RLN2, NMUR1, CALM3, GNB5, CALM1, CALM2, GPR19, CXCL6, CXCL9, PDE3B, ARRB1, ARRB2, PIK3CG, CXCL5, HEBP1, AKAP13, SENP7, GRM2, GPR132, OR56B1, CCR9, CCR4, PF4V1, CCR2, ARHGEF11, ANXA1, PLEKHG2, SPHK2, GPR35, SPHK1, AGTRAP, RHOC, ADRA2C, VAV1, VAV2, RHOB, GAL, ADORA2A, ARHGEF1, DAGLB, GPRC5D, PLCB2, ARHGEF5, ARHGEF6, PTGER4, RGS19, LRP1, ROCK2, ADCY4, ADCY7, P2RY8, GNG2, CNR2, CCL5, OR2AG1, P2RY1, CCL3, KISS1R, GNG8, CCL2, CCL19, SLC12A2, P2RY12, P2RY10, CCL20, GPR55, PLCL2, TSHR, BAIAP3, POMC, PTPN6, GHRL, PDE7B, AGRN, CCL28, LGR4]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[ITGB1, DCLRE1C, CEBPG, GPS2, RBPJ, DOCK11, ABL1, PLCG2, EP300, PTK2B, JAK3, CMTM7, IL10, CR2, POLM, PLCL2, ATP11C, AICDA, KLF6, CLCF1, SP3, BCL3, KIT, FCGR2B, CARD11]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[CREBBP, XRCC6, SYK, XRCC5, RIPK2, ZBTB20, PTPN22, DDX41, TMEM173, NFKB1, RELA, NFKB2, RNF135, POLR3B, POLR3C, PLCG2, POLR3F, EP300, TLR8, CTNNB1, TLR7, LRRFIP1]
GO:0042220;response to cocaine;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;106.24722930474235;6.343086423195323;0.0035559991485312878;0.647506047256038;[EFTUD2, OXTR, SMPD1, MDM2, PTK2B, DNM2]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[PDGFRB, KIT, PTK2B, CCL19, TEK, VAV2]
GO:0002052;positive regulation of neuroblast proliferation;8.0;1.0;0.875;9.628524252492122;500.99868276789744;6.781341354126479;0.016767975042699966;0.7217981122146513;[FOXG1, CTNNB1, DISC1]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[FRMPD3, ATP8A1, RAB3D, PSMD7, PLAU, PSMD2, LAMP2, CPNE1, PSMD1, CPNE3, CAPN1, GOLGA7, B2M, CD97, KCMF1, C6orf120, HLA-H, PRKCD, ADAM10, RNASE3, ARMC8, SCAMP1, UNC13D, CHIT1, ACLY, SLC27A2, DSC1, KPNB1, S100A8, RAB5C, PSMD11, PSMD13, UBR4, PSEN1, IQGAP2, PLD1, C3, RAP1B, COMMD9, CYB5R3, RAP1A, DPP7, ALDH3B1, NCKAP1L, RAB6A, ARSB, AP1M1, CTSA, XRCC6, MGAM, RAB4B, JUP, XRCC5, IDH1, FUCA1, HSPA6, SURF4, PPBP, LYZ, NFKB1, DEGS1, MAN2B1, SERPINA3, PYGB, GPI, SIGLEC9, CRISP3, ITGB2, HK3, ACTR1B, FCGR3B, TIMP2, ITGAX, CTSH, ITGAV, GUSB, SNAP29, CTSB, CAP1, ACTR2, SERPINB1, FCER1G, DBNL, CR1, MME, PLAUR, COMMD3, AMPD3, TMEM173, SERPINB6, VAMP8, CAT, TMBIM1, ALDOC, DOCK2, ALDOA, ACPP, CSTB, PDXK, CLEC12A, FGL2, PGRMC1, NRAS, PSMB1, DYNC1H1, TMEM30A, GSN, AGL, LILRB3, GALNS, FABP5, VAPA, IMPDH1, IMPDH2, RAB18, PTX3, MNDA, PTPN6]
GO:0002053;positive regulation of mesenchymal cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;64.15119587261817;6.444869117505266;0.002147082793528545;0.6527112189764278;[TBX1, FBXW4, MYC, SHOX2, CTNNB1]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[SCARB1, APP, DGKD, SPARC, TFRC, NCF2, WIPF2, TUSC2, ITSN1, LY75, UBE3A, LDLRAD3, FNBP1L, KIAA1109, ANKFY1, AP1S1, FNBP1, ANXA11, TSC2, GAPVD1, UNC13D, RUFY1, RIN3, AMPH, CSNK1G2, CSNK1G1, CDC42SE1, CORO1A, AGER, HSP90B1, HSPH1, CLTCL1, AMBP, CAV2, CAV1, CDC7, MARCH3, DAB2, EHD4, SYNJ1, CDK5, HOOK2, SCGB3A2, HYOU1, PICALM, ITGB1, SH3KBP1, ITGB3, DENND1A, ITGB2, STON1, CLTA, ARRB1, WASL, ARRB2, PIK3C2A, RABEPK, PIK3CG, ITGAV, SCARF1, HRAS, CAP1, TIGD5, FCER1G, DBNL, ANXA1, SYK, EPS15L1, NME1, DNM2, GAK, DNM3, ADORA2A, CTTN, RARA, PIK3C3, RHOU, DOCK2, MET, C9orf72, COLEC12, NLGN3, GTF2A1, CD163L1, LRP1, CEBPE, TMPRSS3, WAS, LRP8, TM9SF4, CLN3, AP2S1, APOL1, ATP9A, MIB1, SNX17, AXL, NEDD4, CD9, FOLR2, FCGR2B]
GO:0010909;positive regulation of heparan sulfate proteoglycan biosynthetic process;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;885.904042282351;8.67846133901236;0.02965041103331486;0.8590579283277371;[TCF7L2, CTNNB1]
GO:1904948;midbrain dopaminergic neuron differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;50.568000767972265;7.8311634786251565;0.0016924654774579861;0.7236063770733796;[NR4A2, RYK, CTNNB1]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CDKN2D, HEXIM2, CDKN1A, CDKN2B, CDKN2C, CDK6, LATS2, CASP3, PLK1, PTEN, TNFAIP3, IPO7]
GO:0003266;regulation of secondary heart field cardioblast proliferation;9.0;0.9326813400603323;0.8625812952104552;9.55953138100517;115.64234114898566;7.697632086000634;0.0038704450869064;0.7898978880348613;[CTNNB1]
GO:0045976;negative regulation of mitotic cell cycle, embryonic;7.0;0.8933024483968273;0.7975705894556142;9.523163736834295;202.68424349991258;9.083926447120524;0.0067836592259655935;0.8154717862087246;[CTNNB1]
GO:1905908;positive regulation of amyloid fibril formation;7.0;1.0;0.8509193652572005;9.628524252492122;262.5761532817171;8.390779266560578;0.00878818754714322;0.7800242071602487;[APP, PSEN1]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[XRCC5, PNKP, MYC, POT1, CTNNB1]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[JUP, CTNNB1, BRCA1]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[CD40, EDA, TNFRSF12A, TNFSF14, CD70, TRADD, TNFRSF10B, TNFRSF10A, TNFRSF13C, RELA, NFKBIA, BAG4, KARS, TMSB4X, TNFSF4, PTK2B, RIPK1, LTBR, RELT, LIMS1, BIRC3]
GO:0001755;neural crest cell migration;6.0;0.7980440201809971;0.722142322680643;9.089527751759436;22.57397290845719;5.825829909099042;7.555305579894227E-4;0.6210535250702663;[TBX1, SEMA6B, LAMA5, ZEB2, SEMA4D, SEMA3C, SEMA4B, CFL1, SOX8]
GO:0001756;somitogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;43.80328827915336;5.845247994956144;0.0014660566383032007;0.5891672661548076;[ZEB2, SEMA3C, EP300, PSEN1, RBPJ, MIB1, HES4, NKX3-1]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[ITGB1, GDI1, DENND1A, ITSN1, KIF14, ARHGAP1, ARRB1, TNFAIP1, ARHGAP6, GPR174, FLCN, AKAP13, PREX1, RASGEF1A, PSD4, NUP62, ARHGDIB, STMN1, TIMP2, FBXO8, HRAS, RALGPS2, PDGFRB, ARHGEF11, PLEKHG4, PLEKHG2, GPR35, RHOH, TSC2, RHOC, GMIP, VAV1, VAV2, RHOB, DNM2, BCR, ITPKB, TIAM2, DEPDC1B, ALS2, MADD, RAPGEF1, ARHGEF1, RHOU, MET, ARHGEF5, ARHGEF6, RASGRP4, P2RY8, ABR, ARHGAP21, PPP2CB, RHOT2, RHOT1, CHN2, ABL1, MFN2, ECT2, A2M, SRGAP2, SRGAP1, ARFGEF2, STARD13, P2RY10, GPR55, MYO9B, ARHGAP26, ARHGAP25, ARHGAP30, DLC1, NF1, KRAS, SPRY1]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[RAP1B, SLC8A3, APP, RAP1A, IGFBP5, RAPGEF1, ITPR2, PKD2, PIK3CG, AQP1]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[OXTR, PCNA, ABCB4, LOC400499, PTEN, WFDC1, TFPI, EGFR, CASP9, SOCS2, CASP8, AIFM1, CASP3, PDGFRB, IL10, ESRRA, NQO1, ENDOG, ANXA1, BAD, ITGA2, CD4, SFRP1, CAT, RARA, CTNNB1, PAM, EZH2]
GO:0030177;positive regulation of Wnt signaling pathway;7.0;0.7307253602413294;0.7162820453778652;9.040737587590003;188.4547261984632;4.948759890378168;0.006307410087620234;0.6039991761920099;[MACF1, EDA, USP34, LRRK1, TNFAIP3, RBPJ, EGFR, ARNTL, UBR5, ABL1, SPIN1, DISC1, DACT1, TRPM4, USP8, CSNK2A1, JUP, EGF, CAV1, NFKB1, DEPDC1B, SFRP1, BMP2, DAB2, ZEB2, SFRP2, TBL1XR1, NAIP, LGR4]
GO:0016322;neuron remodeling;5.0;1.0;0.7902410118609202;9.628524252492122;39.55885145263549;7.474488534686424;0.0013239991574647927;0.6724867031240476;[APP, GNAQ, SCARF1]
GO:0035621;ER to Golgi ceramide transport;7.0;1.0;0.8509193652572005;9.628524252492122;89.55452980698233;8.390779266560578;0.0029973095187954676;0.7800242071602487;[COL4A3BP, PLEKHA3]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[UBE3C, CCNF, UBE2D3, UBE3A, KLHL34, UBE2Z, UBE2L3, HERC5, NPEPPS, HERC4, HERC1, CDC26, TRIM24, TRIM27, SKP2, C18orf25, ATXN7L3, FBXW4, MYLIP, RNF44, FBXO18, ARRDC1, FBXW11, FBXW7, UBE2E3, FBXW9, UBE4A, TRPC4AP, RC3H2, RNF40, MID2, KCTD10, ANAPC5, CBLL1, NAIP, HIST1H2BC, RNF121, ANAPC13, MAGEL2, CDCA3, KLHL14, KLHL15, MYCBP2, UBR4, DTX2, KLHL12, UBR1, RTF1, UBE2J2, FBXO41, ANAPC11, SOCS2, VCPIP1, RNF213, MED30, UBD, HLTF, UBR5, RNF170, LONRF3, SOCS4, WDTC1, SOCS5, UBE2I, UBE2B, KLHL25, FANCL, ZBTB16, PLK1, LNPEP, KLHL24, MARCH6, MARCH3, CNOT4, RNF103, KLHDC8A, UBE2T, CDC16, MDM2, FBXL3, FBXL4, DET1, PPP1R11, TNFAIP3, ARRB1, BRCA1, ARRB2, TNFAIP1, MED18, MED12, TRIM9, TRIM6, TRIM7, TRIM69, ZYG11B, DTX3L, ZFP91, SIRT1, PJA2, DDB1, UBE2R2, TRAF6, MED20, BIRC6, THOP1, RNF166, BIRC3, RNF165, RNF31, HIST1H2BO, PCNA, RNF34, HIST1H2BJ, MGRN1, RNF38, NEDD8, RNF6, NLRC4, RNF135, PCNP, FZR1, ZNRF2, RMND5A, RAB40C, RNF138, RFFL, SASH1, RNF20, PPIL2, TRIM41, FEM1B, SYVN1, FBXL15, UBE2G1, FBXL16, KBTBD11, CHFR, PEX14, MIB1, ITCH, SPSB1, TRIM39, RFWD3, ASB8, NEDD4, TSPAN17, KBTBD2, ASB7, ERCC8, TRIM32, ASB3, KBTBD8, TRIM33]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CDC42SE1, WDR1, EPB41, SH3KBP1, WIPF2, LST1, ITGB2, WAS, WASL, CORO1A, COCH, CCL3, DAG1, CCL2, ANXA7, PTK2B, MYH10, TIGD5, TBCCD1, ANXA1, SEMA4D, MSN, RHOH, CDC7, VRK1, VRK2, PARVB, RHOC, RHOB, VIL1, MKLN1, CFDP1, FES, CDC42EP4, DLC1, TAOK2, KIT, MYH9, RHOU, ALDOA, BRWD1, CSNK1G2, BRWD3, CSNK1G1]
GO:2000060;positive regulation of ubiquitin-dependent protein catabolic process;10.0;0.811012628672052;0.8207473261969463;9.483342242647623;1661.590298646008;5.192106149009898;0.055611931961498426;0.6807655617789147;[DET1, EGF, FBXW7, ZFAND2A, CAV1, PLK1, PTEN, RAD23A, PRICKLE1, PSEN1, SIRT2, CHFR, SMAD7, DAB2, RNF138, UBQLN1, MDM2, PTK2B, TRIB3, LONRF3, RNF166, SOCS4, SOCS5]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[PLEKHG4, RABGAP1, TBC1D9B, RCC2, TBC1D8, TBC1D2B, TBC1D3C, TBC1D3, AKT2, TBC1D7, RUNDC1, PTK2B, TAX1BP3, EVI5L, ECT2, EPHA1, TBC1D17, TBC1D22A, TBC1D15]
GO:1903980;positive regulation of microglial cell activation;8.0;1.0;0.875;9.628524252492122;155.50143499853152;7.697632086000634;0.005204493087195169;0.7686572628545723;[APP, ITGB2, AGER]
GO:0061550;cranial ganglion development;5.0;0.8259837884571596;0.7032329060895001;9.117698628726131;31.419853007278505;8.16763571524637;0.0010515942041217404;0.7079342821725234;[CTNNB1]
GO:0045743;positive regulation of fibroblast growth factor receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;213.73293951330373;7.9853141584524145;0.007153449138352949;0.7592887026755414;[NPTN, CTNNB1, PRKD2]
GO:1904954;canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation;9.0;1.0;0.896240625180289;9.628524252492122;66.41377825634788;8.390779266560578;0.0022228093897200337;0.8253454670833372;[CTNNB1]
GO:0002265;astrocyte activation involved in immune response;5.0;1.0;0.7902410118609202;9.628524252492122;30.94542743681365;8.67846133901236;0.0010357156072335748;0.7340579283277371;[APP, LRP1, PSEN1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[APP, PRKCSH, SERPINA10, CCNF, PCSK9, CHM, MIA3, LAMC1, MSLN, PSMD8, ANKRD9, PSMD7, PSMD4, CDH2, PSMD2, PSMD1, TIMP1, SKP2, RAB8A, FBXW4, FGA, IGFBP5, ESCO1, FBXW11, FBXW7, FGG, FBXW9, ADAM10, COMMD1, RABGGTA, SUMF2, SUMF1, DDB1, PSMA1, PSME2, FAM20C, RAB38, ITIH2, PSMD11, PSMD13, GPS1, RAB1B, SDC2, COPS7B, NEDD8, COPS7A, FSTL1, PSMB10, PSMA7, FBXO41, HSP90B1, C3, TGOLN2, SOCS2, PSMB5, RBBP5, UBD, PSMB1, RBBP7, APOL1, ATG5, WDTC1, SOCS5, MBTPS1, KLHL25, WFS1, FEM1B, RHBDD1, ZBTB16, FBXL15, FBXL16, BTBD6, RAB11A, IL6, SPSB1, COPS5, PSMC1, ASB8, RAB13, STT3A, CALU, ASB7, ERCC8, FBXL3, ASB3, KBTBD8, FBXL4]
GO:0045747;positive regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;187.6437959822434;5.926926025970411;0.006280268983073171;0.6540226378555745;[CREBBP, PRKCI, JAG1, MAML1, SLC35C2, TSPAN17, KIT, EP300, RBPJ]
GO:0061314;Notch signaling involved in heart development;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;57.16383262977075;7.57984905034425;0.0019132220340090946;0.738553198190834;[GALNT11, JAG1, RBPJ]
GO:1904837;beta-catenin-TCF complex assembly;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;6.409777797693995;0.0013529121422039536;0.618037346520142;[TLE4, BCL9, TCF7L2, CREBBP, HDAC1, RBBP5, MYC, TCF7, EP300, CTNNB1]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[KHDRBS1, CDKN1A, DCTN2, DCTN1, DCTN3, PPP2R2A, PKMYT1, CCNB1, ACTR1A, PPME1, CEP70, SKP2, CEP76, CLASP1, DYNC1H1, CDKN2B, ODF2, FBXW11, PLK1, FBXL15, MASTL, TUBG1, CDC25C, CKAP5, CDC25A, TUBA4A, CIT, DNM2, WEE1, CCNY, CENPJ, CDK2, FGFR1OP, MAPRE1, PAFAH1B1, SDCCAG8]
GO:0050772;positive regulation of axonogenesis;10.0;0.7436939687323844;0.7870879962271125;9.36383169826504;884.0118179988558;5.395046993006588;0.02958707998943757;0.6911439659786198;[MACF1, BMPR2, SEMA4D, TNFRSF12A, GDI1, BDNF, SHOX2, TWF2, TRAK1, RAB11A, RTN4, PAK1, ZEB2, RUFY3, ADNP, MEGF8, PAFAH1B1]
GO:0001967;suckling behavior;3.0;1.0;0.6981203125901445;9.628524252492122;23.343114208171034;7.212124270218933;7.812730251086156E-4;0.5669486831672182;[APP, OXTR, DERL2, GLS]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[ITGB1, PRIM2, CDKN1A, USP37, MCM7, MAX, GMNN, MCM10, ACVR1B, PPP6C, GPR132, PPAT, MYC, PIM2, SKP2, CDKN2D, CDKN2C, RANBP3, CDC7, CDC25A, POLE4, WEE1, POLA2, CDK6, LATS2, CCNE2, CCNE1, POLE2, CDK2, POLE3, MCM5, RHOU, MCM6, MNAT1, MCM2]
GO:0016310;phosphorylation;5.0;0.5310727365277519;0.5557773801247963;6.876988939450173;24.405590426795786;2.7321685105510984;8.168331479794688E-4;0.42996423654933263;[APP, OXTR, CCNK, PANK2, GMFB, MAML1, CCNH, TESK2, MYLK, RPS6KA4, RPS6KA5, RASSF2, RPS6KA2, MYC, AKT2, TRIM24, CPNE3, TRIM27, SEPHS1, SEPHS2, EPHB4, PDK2, PDK1, PRKCI, CSNK2A1, DAPK1, PRKCE, PAQR3, PRKCD, ZFYVE21, PRKCA, PRKAB1, MAPK8IP1, BCR, KARS, PRKD3, ULK2, TRIB3, ULK1, PRKD2, EPHA1, CTBP1, ATP5J, ATP5I, ATP5O, ATP5L, NUAK1, STK38L, PIP5K1B, TRPM7, TRPM6, N4BP2, SULT1A3, SPTBN1, CHKB, CHKA, PLK1, EIF2AK3, CDC7, ERLIN2, SETX, GNPTG, UCK2, UCK1, OGDH, CALM1, GPI, SMG1, FASTKD1, CAB39L, PRKAG1, PRKAG2, AATK, AKAP13, PPP3CB, ZMYM2, CAMKV, FASTK, PBK, CTSH, TK2, HRAS, JAK3, IKBKE, DUSP5, MAP4K2, TPI1, RIPK3, SYK, SPHK2, MMD, RIPK2, IL15, SPHK1, TYK2, GFRA2, VAV1, NME1, CIT, GAK, ITPKB, PDIK1L, KIT, ITPKA, FASTKD5, RARA, FAM20C, ALDOC, TLR7, ALDOA, STK40, HBEGF, ARHGEF6, PTGER4, GPS1, GPS2, NOL9, COX5B, EGFR, PAK1, NRAS, MAP4K3, MAP3K3, MAP3K1, AGK, TPK1, GLYCTK, GTF2H4, AXL, CAMK4, TAOK2, PKN2, CAMK1, CD86, DGKD, CCNT1, DGKA, CD80, IL5RA, BUB1B, STK19, IGF1R, GRAP2, CFL1, STK16, NEK1, PIM3, PIM2, MAP3K9, MAP3K5, PDGFRB, KCNH3, FBXW11, ADAM10, VRK1, VRK2, ERN1, ILF3, CCNE1, CSNK1G2, CSNK1G1, SHC1, AK2, AK3, AK5, PKMYT1, STK4, RASGRP4, STK3, RASGRP3, SOCS2, CCNB1, STK35, STK38, GRK6, ABL1, MBP, RIPK1, CYC1, MARK2, SOCS5, NEK6, DOLK, CLK4, EIF2S1, CLK3, NFKB1, CLK2, SMAD7, CLK1, CDK9, CDK8, BMP2, FER, PAN3, CDK6, CDK5, STK24, PTPRA, FES, CDK2, NF1, FGFR1OP, MNAT1, FGF13, GALK2, MAP3K11, CIITA, BMPR2, MAST4, MAST3, ADPGK, YWHAB, LRRK1, PIK3C2A, PIK3CG, HK1, HK3, SPRED1, RASGEF1A, TLK1, ITGAV, CLEC1B, SCYL1, CAMK1D, KSR1, SH2D3A, DCAKD, CAD, SH2D3C, BPGM, OXSR1, IRAK4, ATP5F1, MASTL, SPTB, COASY, TGFBR1, LATS2, IMPAD1, TRAF6, PIK3C3, BIRC6, MET, GAPDH, RBKS, PRPS2, PDXK, STOML2, CAMK2D, ROCK2, PNKP, TAF1L, IL2RG, ACVR1B, MAPK7, PABPN1, RPS6KC1, CCL5, MKNK1, MKNK2, PHKG2, CCL3, CCL2, PTK2B, NCAM1, CSK, BPNT1, ANGPT1, EGF, MAPK13, P2RX7, SNRK, WEE1, RAD50, TNIP2, IL2RA, RPS6KB2, CCM2, KRAS, PTPN6, TEK]
GO:0032467;positive regulation of cytokinesis;7.0;0.7043150770688792;0.7030769037916401;9.015419779605713;142.0565341908292;6.193554689224359;0.004754504356786525;0.6676580400938822;[SVIL, SPAST, KIF3B, PRKCE, NUP62, KIF14, PKP4, KIF23, PKN2, ECT2, CIT]
GO:1903076;regulation of protein localization to plasma membrane;7.0;0.7307253602413294;0.7162820453778652;9.117698628726131;62.75471671371763;5.346256828837156;0.0021003438928297916;0.6243271881103005;[ITGB1, PRNP, PRKCI, LRP1, PRKCE, STX7, CIB1, ACSL3, RAB11A, EGFR, VIL1, VAMP8, CLIP3, DAB2, CDK5, RER1, TMBIM1, PPFIA1, CSK, SPTBN1, APPL1, PICALM]
GO:0036023;embryonic skeletal limb joint morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;57.116566179316244;8.67846133901236;0.0019116400684494259;0.7947362817240173;[CTNNB1]
GO:0042129;regulation of T cell proliferation;8.0;0.6696747006330769;0.7098373503165385;8.89763674394933;80.78677358774456;4.7664383335842135;0.002703860608605884;0.6187558780415471;[CD86, TFRC, SDC4, CD80, EBI3, IL27, TNFRSF13C, CORO1A, AGER, HLA-DMB, CCL5, CASP3, CTLA4, NCKAP1L, IL12A, CCL19, IL12RB1, JAK3, CCR2, HLA-DPA1, HAVCR2, IL10, PRNP, ANXA1, RIPK3, SYK, RIPK2, IL15, GLMN, PDCD1LG2, CCDC88B, ITCH, CD4, TWSG1, IL6, GPAM, IL23A, TNFSF4, IL2RA, TRAF6, HLA-DPB1, CTNNB1, PTPN6, PDE5A, CD24, ZP3, CARD11]
GO:0045638;negative regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;279.0827475916144;5.4730085344763;0.00934064840372507;0.6308092762312435;[KLF13, RBM15, FBXW7, ZBTB16, GPR55, CIB1, LILRB3, TOB2, NME1, NFKBIA, ITPKB, SFRP1, MEIS1, CDK6, MYC, RARA, CCL3, NF1, PTK2B, CTNNB1, HOXA5, GABPA, C1QC]
GO:0061549;sympathetic ganglion development;5.0;1.0;0.7902410118609202;9.628524252492122;31.419853007278505;7.57984905034425;0.0010515942041217404;0.6778748447945537;[CTNNB1]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[APP, CDKN1A, TUSC2, TFCP2L1, ACRBP, MECP2, CCNB1, PTK2B, SOX8, FBXO5, CCL19, SCARF1, HOXA5, HBZ, XBP1, G6PD, FZD5, FEM1B, IL15, FGG, RUNX2, NR4A2, AXL, GNAQ, TMEM79, SLC26A8, FAM20C, CTNNB1]
GO:0035050;embryonic heart tube development;5.0;1.0;0.7902410118609202;9.628524252492122;33.009488292418915;7.004484905440688;0.0011047978665365144;0.6484506956670166;[IFT122, CTNNB1]
GO:0045636;positive regulation of melanocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;190.69673191605972;8.390779266560578;0.006382448001314043;0.7800242071602487;[ZEB2]
GO:1990000;amyloid fibril formation;5.0;1.0;0.7902410118609202;9.628524252492122;65.1103285866179;7.697632086000634;0.0021791841023027143;0.6838982747154925;[APP, GSN, RIPK3, MDM2, RIPK1]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, FZD1, TCF7L2, HDAC1, CAV1, CHD8, FZD6, KLHL12, PRICKLE1, STK4, STK3, AES, CYLD, SFRP1, BMP2, DAB2, SFRP2, LATS2, CDH2, RAPGEF1, DVL3, EMD, DACT1]
GO:0006868;glutamine transport;10.0;0.8933024483968273;0.861892236059334;9.4949928598676;85.82177420350179;8.16763571524637;0.0028723775480089153;0.8329342821725234;[SLC1A4, SLC38A2]
GO:0072554;blood vessel lumenization;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;49.89975243090898;9.083926447120524;0.001670099807000936;0.8154717862087246;[RBPJ]
GO:0048599;oocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;7.292166977892469;0.0024359751381706407;0.6631627702307852;[CTNNB1, ZP3]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[SPON2, APP, FCN3, NCF1, NCF2, DEFB1, PRDM1, IPO7, HERC5, GRAP2, TRIM27, B2M, MAP3K5, WRNIP1, RNASE3, MR1, MID2, ADAM15, IL23A, PSPC1, TRIM14, SERPING1, MATR3, CFB, NAIP, S100A8, HIST1H2BC, ANKRD17, CFH, ZC3HAV1, CORO1A, AGER, C2, C3, CLEC7A, PRDX1, NLRP2, ABL1, SLAMF7, NLRP3, XRCC6, APOBEC3F, APOBEC3H, XRCC5, NONO, NFKB1, ANKHD1, NFKB2, TREML1, CYLD, FER, FES, TREML4, SERINC3, APOBEC3A, CRISP3, HMGB3, IL27, LYST, PIK3CG, PPP6C, C1QBP, TNFAIP8L2, JAK3, IKBKE, HAVCR2, FGA, MAP4K2, CR2, FCER1G, ANXA1, CR1, DTX3L, SYK, RIPK2, IRAK4, TYK2, TMEM173, SIRT2, SFPQ, ELF4, TLR8, TLR7, TLR10, COLEC12, HIST1H2BJ, CEBPG, DEFB123, NLRC4, LILRA2, RELA, RNF135, SUSD4, PTK2B, CSK, APOL1, PPP1R14B, MX2, MX1, ITCH, POLR3B, POLR3C, AXL, POLR3E, POLR3F, PTX3, PTPN6, TBKBP1, TRIM32, CD244, LGR4, C1QC]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[DYNC1H1, DCTN2, ODF2, DCTN1, RAB3IP, DCTN3, PLK1, TUBG1, CKAP5, RAB11A, TUBA4A, ACTR1A, CENPJ, CEP70, MKS1, FGFR1OP, MAPRE1, CEP76, CLASP1, PAFAH1B1, SDCCAG8]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[APP, CCL3L1, SHC1, PTEN, CIB1, PTPN22, ARRB1, ARRB2, AGER, EGFR, IGF1R, RAP1B, RAP1A, CCL5, P2RY1, ABL1, CCL3, GCNT2, NPTN, CCL2, PTK2B, CCL19, HRAS, PDE8A, EPHB4, HAVCR2, PDGFRB, FGA, CD74, ANGPT1, CCL20, RYK, FBXW7, RIPK2, FGG, GPR55, PRKCA, CD4, BMP2, KARS, AXL, KIT, RAPGEF1, PRKD2, TEK, EPHA1, MET]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[VASP, NCKAP1, ACTR2, MAGEL2, TIGD5, GSN, WIPF2, PRKCE, ARPC1A, WAS, ARPC4, WASL, IQGAP2, ACTR3B, VIL1, BAG4, FER, ARPC2, CTTN, CDC42EP4, PTK2B, NCKAP1L, TRIM27, PFN2]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[XRCC5, PNKP, POT1, CTNNB1]
GO:0050427;3'-phosphoadenosine 5'-phosphosulfate metabolic process;10.0;0.9326813400603323;0.8815816818910864;9.598671289342441;1067.6044110768958;6.599019797332524;0.035731758857152955;0.7527151911823093;[SULT1A1, TPST2, IMPAD1, BPNT1, SULT1A3]
GO:0032331;negative regulation of chondrocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.567899630675686;230.26794502196225;6.781341354126479;0.007706860892188918;0.6977174774718518;[CTNNB1, TGFBR1]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[SFRP1, TWSG1, CDK6, IGFBP5, SEMA4D, SUFU, CCL3, PTK2B, RBPJ, TRPM4]
GO:0014005;microglia development;5.0;1.0;0.7902410118609202;9.628524252492122;67.63861772680754;8.67846133901236;0.0022638036645123614;0.7340579283277371;[APP, TSPAN2]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[MAP4K2, DBNL, SYK, FZD5, RIPK2, MAPK8IP3, AGER, ERN1, PAK1, ZEB2, TRAF6, DVL3, PTK2B, RIPK1, CCL19, MAP3K9, ARHGEF5, SASH1, MAP3K11, MAP3K5]
GO:1901186;positive regulation of ERBB signaling pathway;7.0;0.7980440201809971;0.7499413753476991;9.34084218004034;187.6437959822434;6.221725566191056;0.006280268983073171;0.6690987000520388;[PDE6H, NCF1, EGF, PDE6G, FBXW7, NUP62, PLAUR, ADRA2C, RBPJ, RTN4]
GO:1901189;positive regulation of ephrin receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;186.95064880168647;9.777073627680469;0.006257069970731893;0.8509193652572005;[RBPJ]
GO:0021957;corticospinal tract morphogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;69.80210411808247;8.390779266560578;0.002336213607016992;0.8615337942327104;[ZEB2]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[VPS29, AHCYL1, RPL3, NUP107, TFRC, ARL6IP1, ZDHHC6, IFIT1, RBPJ, PEX26, RPS15, AKT2, LONP2, AP1S1, ARFIP1, HOMER3, TRIM27, MLYCD, TBC1D22A, SIL1, GOLGA7, VPS18, GSTK1, ARL11, ACOT8, PRKCI, C16orf70, ARRDC1, COG5, COG4, COG3, AP1B1, ATG10, COG1, MYO7A, ANK3, SCAMP1, SYTL4, SYTL3, SCAMP3, BCR, RUFY1, NUP93, DOPEY2, UNC50, ACOT2, KIF20A, RPL29, RPL28, ACOT4, STX1A, BLZF1, MACF1, TBC1D9B, VPS26A, VPS26B, ABCB9, VPS8, VPS11, ATP6V0A2, VTI1A, SSR1, SPTBN1, VPS16, SEC31A, RAB11FIP5, BBS2, CTSA, XBP1, EGR2, PMM1, RAB3IP, PMM2, RAB27B, POLA2, NPLOC4, RPS27, HYOU1, CD24, ARF3, ARF4, TRAM1, AHCTF1, GDI1, DENND1A, SRP54, ARHGAP1, CLTA, CHM, MIA3, LYST, TRAM2, XPO5, KIF13B, TMED2, TMED1, AP3S2, TMED7, RAB8A, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, ANXA1, SYK, SSR2, SSR3, ZDHHC12, BTN3A2, COMMD1, ZDHHC17, RHOB, VAMP8, AFTPH, LSG1, GAL, CTTN, AGPS, EXOC4, EXOC3, SLU7, VAMP5, ARF5, PAFAH1B1, EXOC1, NAPA, RABGAP1, TOMM40, STX17, STX16, ZDHHC23, HSD17B4, ZDHHC24, DERL2, PRICKLE1, TRAK1, RGPD1, NAPG, STX11, ARNTL, GGA3, SNX25, LMAN2, ASNA1, LMNA, AP2S1, HEATR3, STX5, MFN2, CCL19, BID, ATP6V0E2, RAE1, RPL19, PEX16, CD74, MON2, PEX19, RANBP3, AGK, SYVN1, SNX22, RAB11A, YIF1A, PEX14, ARCN1, DHRS4, CENPF, SPCS2, SNX19, GPAM, SNX17, SNX14, NEDD4, TAOK2, RAB3GAP2, UBAP1, COPG2, APBA3, APBA2, RAB3B, STEAP3, SYS1, DGKD, NCF1, PDCD6, RAB3D, UBE2D3, BCCIP, TBC1D3C, PARK7, IPO7, IPO4, RAB43, RPH3A, EIF4ENIF1, IPO8, IPO9, LAMP2, KPNA4, KPNA5, RPS9, RPS7, VPS33A, VPS33B, STX7, TOMM34, TSC2, TBC1D2B, RPSA, CLIP3, RINT1, CLIP1, RAB36, RAB35, CHMP4B, RAB38, SLC27A2, KPNB1, PPID, CARD11, RTN2, COPB2, COPA, SUCNR1, RAB5C, PSEN1, HSP90B1, MTM1, NCKIPSD, RAP1A, CLTCL1, NLRP3, ECT2, RAB6A, TBC1D17, TBC1D15, ATP6V1F, AP1M1, DNAJC19, TOR1A, RAB4B, VTA1, IDH1, ASPSCR1, NUP153, TIMM44, HOOK3, NFKBIA, DAB2, PAN3, AMACR, CDK5, TMEM115, HOOK2, BCL3, PLEKHM1, PLEKHF2, RTP4, TTC26, SFT2D3, YWHAB, ARRB1, ARRB2, GPR89B, SEC61A2, AP1G2, AP1G1, NUP62, TLK1, ITGAV, EVI5L, TNPO1, TNPO2, SNAP29, ARL5A, TNPO3, EIF5A, PDCD6IP, DTX3L, VPS13C, RHBDF2, FGG, VPS13D, TBC1D8, VPS13B, VPS37A, VPS37B, SENP2, ARFGAP1, DNM2, PEX7, TBC1D3, ACOX2, ACOX1, PEX6, EHHADH, GORASP1, CAT, RPL37A, MYH9, LCP2, ACOX3, CHMP6, SFT2D2, SEC22C, LRP1, VPS4B, RAB1B, GOSR2, GOSR1, RRBP1, NLRC4, RAB21, AP3M2, AP3M1, RAB20, RAB40C, VPS53, VPS52, VPS54, RAB28, TIMM8B, ARFGEF2, MBTPS1, MX2, RPL23A, GDAP1, MCM3AP, RAB15, VPS41, RAB13, RAB18, RUNDC1, VPS45, SEC24C]
GO:0006685;sphingomyelin catabolic process;8.0;1.0;0.875;9.628524252492122;779.439587268313;8.16763571524637;0.026087141535783887;0.7926932703116032;[SMPD4, SMPD1, ENPP7]
GO:0060769;positive regulation of epithelial cell proliferation involved in prostate gland development;7.0;1.0;0.8509193652572005;9.628524252492122;208.66083702352876;8.67846133901236;0.006983690432616063;0.7947362817240173;[CTNNB1]
GO:0000578;embryonic axis specification;4.0;0.7866048967936545;0.6433024483968273;8.753055515138222;24.589985525707924;6.409777797693995;8.230046859952432E-4;0.5777963346592216;[FZD5, TMED2, CTNNB1]
GO:0022009;central nervous system vasculogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;8.390779266560578;7.282666309192915E-4;0.7193458537639684;[CTNNB1]
GO:0006687;glycosphingolipid metabolic process;7.0;0.6763753087927167;0.6891070196535589;9.040737587590003;147.45961877692685;5.734022359845919;0.004935340735422783;0.64415753539903;[GLTP, CTSA, B3GALNT1, ST6GALNAC1, B3GALT4, GBA2, SUMF1, GALC, UGT8, CLN3, ALDH5A1, SMPD4, SMPD1, KIT, BAX, B4GALT6, ENPP7, ST6GALNAC6]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[MTPN, MACF1, BMPR2, GDI1, CPNE5, TWF2, DERL2, CIB1, EGFR, RTN4, PAK1, PTK2B, CSNK2A1, SEMA4D, TNFRSF12A, NCBP1, PARP2, BDNF, SPHK1, H3F3A, ADAM10, RAB11A, TGFBR1, SFRP1, SFRP2, RUFY3, FGFR1OP, ADNP, MEGF8, TRIM32, EIF4G2, S100A8, PAFAH1B1, HBEGF]
GO:0051124;synaptic growth at neuromuscular junction;5.0;1.0;0.7902410118609202;9.628524252492122;69.82350741158206;8.16763571524637;0.0023369299559887094;0.7079342821725234;[APP]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[SUV39H1, HP1BP3, PTEN, MPL, RORA, AQP3, AQP1, TXN2, MECP2, NPEPPS, ALKBH5, PLAU, MYC, FUNDC1, CASP3, NPPA, CAPN2, EP300, ATP7A, NKX3-1, ENDOG, ITGA2, PRKCE, SIRT4, ARNT, AGTRAP, SIRT1, SIRT2, SFRP1, DDIT4, CAT, PPARD, BECN1, ABCB4, PSEN2, ITPR2, THBS1, AGER, TM9SF4, HSP90B1, PDLIM1, CCNB1, PAK1, UCP3, KCNMB1, LMNA, UBQLN1, SCAP, PTK2B, CREBBP, EGLN2, BAD, CAV1, NR4A2, SLC8A3, BMP2, TBL2, MDM2, NF1, HYOU1, TEK, CD24, ZNF354A, PAM, KCNK3]
GO:0051000;positive regulation of nitric-oxide synthase activity;7.0;1.0;0.8509193652572005;9.628524252492122;123.23454311126406;6.832634648514029;0.0041245492540456985;0.7003406189322132;[DHFR, SCARB1, PTK2B, KRAS]
GO:0048643;positive regulation of skeletal muscle tissue development;8.0;0.7866048967936545;0.7683024483968273;9.310070521373587;215.42578871941666;6.518977089658987;0.007210107277816175;0.7083807915285978;[TBX1, SHOX2, CTNNB1, ARNTL, MTM1]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[TOP2B, APP, C12orf57, PITPNA, PTEN, RTN4, STMN1, NRCAM, NPTX1, NEFH, RAB8A, RYK, MAP1S, OMG, ANK3, GP5, NR4A2, LRFN3, ZEB2, LRFN4, ALS2, CDK5, NFIB, TAOK2, PAFAH1B1, PICALM]
GO:0032960;regulation of inositol trisphosphate biosynthetic process;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;184.2484210461476;7.9853141584524145;0.006166628839601098;0.7833693374183408;[P2RY1, PTK2B]
GO:0070329;tRNA seleno-modification;11.0;1.0;0.9324289523296623;9.628524252492122;512.907165443018;9.083926447120524;0.017166541240897646;0.8969813732811862;[SEPHS1, SEPHS2]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[NCKAP1, ITSN1, TESK2, PREX1, SAMD14, MYC, AKT2, STMN1, GTSE1, PRKCI, DAPK1, PRKCE, PRKCD, PRKCA, BCR, NISCH, DEPDC1B, PRKD3, DDIT4, LGALS12, PRKD2, ATF4, XPA, ABR, RHOT2, RHOT1, PPP4C, PLCG2, SULT1A3, GSTM2, HOMER2, PLK1, EIF2AK3, NFATC3, NFATC1, SETX, MLLT11, CYLD, COL1A2, DCHS1, BTG2, CDKN1A, ARHGAP1, PRKAG2, CHM, ARHGAP6, BBC3, ING4, AIFM1, JAK3, IKBKE, TEAD2, DUSP5, RIPK3, RIPK2, SPHK1, TMEM173, GMIP, SIRT1, SIRT2, CIT, ITPKB, CDC42EP4, RAPGEF1, PLCB2, EXOC1, HBEGF, GPS1, ADCY4, GPS2, TANK, ADCY7, EGFR, NRAS, CHN2, STAT4, BID, P2RY12, GSN, CCL20, CLCF1, TAOK2, PKN2, LGR4, RAB3B, DGKD, DGKA, RAB3D, IL5RA, DEFB1, PARK7, RAB43, GRAP2, CFL1, NEK1, MAP3K9, MAP3K5, IFNAR2, USP8, KCNH3, IGFBP5, CDC25C, RAB36, RAB35, RAB38, KPNB1, RAB5C, SHC1, ITPR2, KRCC1, FHIT, RAP1B, SOCS2, RAP1A, TBXA2R, STK38, ABL1, DVL3, MBP, RAB6A, SOCS4, SOCS5, RAB4B, TNFRSF10B, RFXANK, DHCR24, CORO2A, NFKB1, NFKB2, CNOT4, CNOT6, IRAK1BP1, CNOT7, SH3BP5L, STK24, PTPRA, CNOT1, RCAN3, BCL3, CNOT3, CDK2, PLEKHM1, MDM2, NF1, CNOT8, MAP3K11, BCAR3, TRADD, LRRK1, PTEN, PIK3C2A, PIK3CG, TLK1, ITGAV, NKX3-1, KSR1, SH2D3A, SH2D3C, ADRA2C, SPTB, TFDP1, TFDP2, ADORA2A, TRAF6, PIK3C3, LCP2, LCP1, MET, BIRC3, PPP1R15A, RNF31, ROCK2, RAB1B, IL2RG, RAB21, FZR1, RAB20, CCL5, TIFA, PHKG2, CCL3, SH3BP5, CCL2, ZNF622, RAB28, SH2B3, E2F7, SH2B2, E2F8, ANGPT1, PLCL2, CDC5L, TPCN2, SNRK, P2RX4, RAB15, IL2RA, RAB13, RAB18, CCM2, PTPN6, OXTR, CALML4, RAPGEFL1, RPS6KA4, RPS6KA5, RPS6KA2, ARL6IP5, PDK2, PDK1, PAQR3, TIAM2, KARS, TRIB3, PAXIP1, CRHR1, NUAK1, RRAS, TP53BP2, STK38L, RALGDS, CCR10, PAG1, SPTBN1, TRPM4, XBP1, SETDB1, RAB27B, CCDC88A, PPP1R1C, CALM3, CALM1, RGL1, CD24, CALM2, CD40, GDI1, BRCA1, AKAP13, PPP3CB, AKAP11, CAMKV, NKIRAS1, C1QBP, UIMC1, CCR9, CTSH, HRAS, CCR4, RAB8A, RAB8B, CCR2, RALGPS2, MAP4K2, DBNL, RHOH, TYK2, GAB2, RHOC, GFRA2, VAV1, VAV2, RHOB, GAL, KIT, DEPDC1, TLR8, TAX1BP3, ARHGEF1, TLR7, RHOU, ARHGEF5, ARHGEF6, PTGER4, PCNA, WAS, RELA, PPP2CA, PAK1, PERP, MAP4K3, MAP3K3, MAP3K1, MYO9B, RAB11A, ITCH, AXL, CAMK4, CAMK1, TJP2, RTKN, CD80, SIRPG, IGF1R, DOCK11, ARHGDIB, EP300, SNIP1, PDGFRB, FBXW11, TSC2, ERN1, DOK2, TIPRL, ELMO1, CARD11, DIABLO, CLEC16A, PSEN2, PSEN1, RASGRP2, STK4, PLD1, RASGRP4, STK3, RASGRP3, CCNB1, ZMAT1, RIPK1, ECT2, MARK2, PRNP, IFT122, CNOT10, NFKBIA, SELP, FER, ARHGAP30, GNAQ, NMUR1, FGF13, LSM14A, MCTP1, MAST4, PRKCSH, MAST3, YWHAB, DOCK8, ATP2A2, TNFAIP3, PKD2, POLB, CASP9, FLCN, SPRED1, CASP8, RASGEF1A, CASP3, CASP2, ARHGEF11, CAMK1D, OXSR1, IRAK4, MASTL, TGFBR1, PJA2, LATS2, ALS2, DOCK2, ZP3, CAMK2D, RGS19, TUFT1, RAP1GDS1, GNG2, MAPK7, PABPN1, RAB40C, MKNK1, MKNK2, PTK2B, NCAM1, ARFGEF2, EGF, NOS3, BAD, TSHR, MAPK13, TNIP2, ASB8, RPS6KB2, BAX, ASB7, KRAS, TEK, ASB3]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[BCAR3, APP, ANGPT1, RIPK2, CAV1, ATP2B4, ARRB1, CREBL2, PARK7, ARRB2, STK4, GFRA2, EGFR, IL6, BAG4, TRIM6, PAK1, SFRP2, MTCP1, PRKD2, CAMK1, PFN2]
GO:0035315;hair cell differentiation;6.0;0.811012628672052;0.7286266269261705;9.143016436710422;49.42682886488536;7.292166977892469;0.0016542714808497024;0.6960420709600095;[JAG1, CTNNB1]
GO:0000904;cell morphogenesis involved in differentiation;5.0;0.6519675769143192;0.6162248003180799;8.188162670101956;44.36123180790924;4.981283082083729;0.0014847305060940845;0.5449840603320351;[ITGB1, LAMA5, ST14, ITGB3, KIF14, LAMC1, PARVB, COCH, FER, PARVG, VSIG1, TBC1D20, HRH2, AXL, COL4A4, COL7A1, ABL1, CTNNB1, ITGAV, TEK, EPHA1, SRGAP2, MET]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[KCNG1, SLC23A2, CCT8L2, STEAP3, ATP8A1, SLC35B1, PKD2L1, COX6A1, BEST3, AQP1, ARL6IP5, PMPCB, SLC16A7, CLCC1, SLC39A3, SLC30A7, KCNH3, CHRNB3, SLC35C2, KCNK12, PRKCE, CACNA2D3, ATP11C, SLC6A12, ATP1B2, CACNA2D4, TRPC4AP, SLC5A6, COX7A2L, SLC9A6, SLC9A8, SCNN1A, VDAC3, VDAC2, XPR1, SLC27A5, SLC35D1, KCNE3, COX15, ITPR2, ATP5J, ATP5I, SLC1A4, PSEN1, ATP5O, ACACA, MTMR6, ATP5L, KCNV2, ANKH, KCNMB1, ATP6V0A2, PLCG2, SLC38A6, COX11, TRPM7, CYC1, KCNN3, TRPM6, SLC38A2, NTSR1, ATP6V1F, TRPM4, SLC37A1, GRIN3A, SLC6A9, SFXN3, SLC26A8, SFXN4, FXYD5, CALM1, SFXN5, PICALM, SLC25A1, KCNK6, CLIC5, SLC25A3, COX4I1, ARHGAP1, ATP2A3, ATP2A2, PKD2, GPR89B, COX7C, PANX1, LASP1, CPT2, NNT, ITGAV, ATP7A, SLC36A1, ABCC1, KCND1, TSC22D3, ZDHHC13, HTR3B, NIPA2, ATP5F1, SLC39A14, ZDHHC17, NDUFS7, SLC25A19, SLC25A10, SLC25A13, STOML2, SLC24A3, SLC20A2, SLC20A1, KCNA3, ATP2C2, ATP1A1, COX5B, CLCN3, RHD, SLC25A29, SLC25A28, UCP3, CCL3, CHRNA10, SLC25A20, CCL19, APOL1, ATP6V0E2, SLC36A4, SLC25A22, TIMM8B, SLC35A2, SLC12A2, P2RY12, ATP13A1, SLC31A1, ATP2B4, TPCN2, P2RX7, SLC8A3, SLC25A38, P2RX5, P2RX4, BAX, ATP13A3, PLP2, FOLR2, KCNK3]
GO:1901992;positive regulation of mitotic cell cycle phase transition;8.0;0.7866048967936545;0.7683024483968273;9.34084218004034;187.2036739141087;5.528578385631111;0.006265538493536848;0.6577317557463623;[ANKRD17, APP, ANXA1, RCC2, VPS4B, TMOD3, NSMCE2, MEPCE, CDC7, CDC25C, RAB11A, CDC25A, ANAPC11, LSM10, MECP2, CCNB1, RAD51C, ESPL1, SIN3A, MDM2, ANAPC5, MTA3]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[BCCIP, CIB1, CALML4, TUBB6, TUBB1, STMN1, ZNF207, DAG1, FBXO5, MAP1S, TUBA4A, EML3, CLIP1, KATNAL1, MAP7D3, MAP7D1, KIF20A, PHLDB2, KPNB1, TUBGCP2, ATXN3, CCNB1, SPAST, KIF3B, FIGNL1, MAP4, SRGAP2, MARK2, BBS2, UVRAG, UBE2B, CEP350, NEK6, PLK1, HOOK3, NDC80, CCDC88B, NSFL1C, CCDC88A, FER, SON, CDK5, HOOK2, FES, KIF4A, TBCE, FGFR1OP, MAP6D1, CALM1, FGF13, TUBA8, SPAG16, NUMA1, BICD1, MECP2, TUBA1C, TUBA1B, KIF19, NUF2, NEFH, TUBG1, CKAP5, IQCG, NCOR1, PSRC1, ESPL1, MYH9, KIF2C, MAPRE3, VAMP4, MAPRE1, GAPDH, MAPRE2, GAS8, PAFAH1B1, MCPH1, BIRC3, HDAC3, DCTN2, DCTN1, VPS4B, TUBD1, KATNA1, LMNA, FSD1, DISC1, CLASP1, DYNC1H1, RANBP3, CRIPT, RAB11A, PEX14, CENPE, NIN, WEE1, TTLL5, TTLL3, CENPJ, SPRY1, SPC25]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[BECN1, PCNA, TNFAIP3, PARK7, RELA, AQP1, PPP2CB, MAP1LC3A, MAPK7, AIFM1, CASP3, ABL1, PTK2B, KPNA4, ECT2, MAP3K5, PDGFRB, NQO1, ANXA1, BAD, PRKCD, SIRT1, RHOB, MAPK13, SOD1, SETX, IL6, STK24, AXL, CAT, PPIF, MDM2, SDC1, EZH2]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[CYFIP2, APP, MAML1, GFI1, ITSN1, RBPJ, GPR174, RASSF2, TFG, PPP2R1B, ZC3H12A, ARL6IP5, CPNE1, IL12A, SKP2, EPHB4, CDK5RAP3, PRKCI, CSNK2A1, RSAD2, SLC35C2, PRKCE, PRKCD, PRKCA, MAPK8IP3, RC3H2, MAPK8IP1, NUP93, DEPDC1B, SFRP1, TWSG1, SFRP2, KARS, IL23A, PRKD2, EPHA1, NAIP, STX1A, ATF4, MACF1, SEH1L, SHOX2, PLA2G6, MTDH, C3, TP53BP2, NTSR1, PAG1, TRPM4, CREBBP, XBP1, GSTM2, JAG1, JUP, TNFSF14, FZD5, STARD10, GDF1, PUM2, MLLT11, CYLD, ARL2BP, TREML4, CALM3, CALM1, CD24, CALM2, EZH2, CDKN1C, HRK, CD40, TGFB1I1, ARHGAP1, SECTM1, ARHGAP6, BBC3, AKAP13, ING2, TRIM6, CASP10, C1QBP, HYAL2, TIMP2, SPIN1, CTSH, HRAS, IKBKE, HAVCR2, TMED4, DUSP5, MAP4K2, FCRL2, SEC13, DBNL, TNFRSF12A, RIPK3, SYK, GPR35, RIPK2, IL15, SPHK1, FCRL3, ATPIF1, ZDHHC13, RHOC, ZDHHC17, SIRT1, VAV1, ITPKB, ZEB2, KIT, RAPGEF1, TLR7, ARHGEF5, GAS8, PAFAH1B1, HBEGF, RNF165, AVPI1, PPARD, SLC20A1, TUBD1, GPS2, RELA, EGFR, ARNTL, BCLAF1, PAK1, CHN2, GCNT2, PLAGL2, CCL19, MSX1, BID, DISC1, MAP4K3, APOL3, MAP3K3, CD74, CDKN2B, P2RY10, MAP3K1, GSN, CCL20, RYK, BIK, GDF15, GPR55, G0S2, SORBS3, MPP7, PPP1CA, NLRP12, AXL, NEDD4, CLCF1, TAOK2, CTNNB1, GHRL, LGR4, LIMS1, CD86, NCF1, CD80, CIB1, UBE3A, PARK7, IGF1R, CDH2, GRAP2, EP300, PIM2, MAP3K9, PDE8A, MAP3K5, PDGFRB, USP8, FBXO18, IGFBP5, RPS7, FBXW7, MID2, ERN1, TBL1XR1, MADD, PPIF, CARD11, S100A8, ANKRD17, KHDRBS1, CCL3L1, SHC1, CLEC16A, PSEN1, STK4, AGER, RASGRP4, RTN4, STK3, RAP1B, SOCS2, BAG4, RAP1A, UBD, UBR5, ABL1, DVL3, RIPK1, ECT2, CD300LF, UBE2I, BDNF, CAV2, CAV1, NEK6, TNFRSF10B, TNFRSF10A, NFKB1, BMP6, SSH1, SELP, CXCL10, IL6, CXCL11, BMP2, DAB2, CDK5, STK24, RHEB, NF1, PDCL, SERINC3, IL7R, LSM14A, MAP3K11, BCAR3, ITGB1, CXCL9, BMPR2, EDA, NUMA1, YWHAB, ITGB3, TRADD, USP34, LRRK1, PTEN, TNFAIP3, PTPN22, ARRB1, ARRB2, PKD2, PIK3CG, FLCN, PTBP1, SPRED1, LASP1, CASP8, ADAMTS3, RASGEF1A, NUP62, NPTN, CASP2, ITGAV, DACT1, NKX3-1, FGA, KSR1, SH2D3A, BUD31, FGG, ITGA1, SH2D3C, PLAUR, ZFP91, ARNT, IRAK4, ADRA2C, YWHAZ, TGFBR1, DUSP22, SFPQ, TFDP1, ALS2, TFDP2, ADORA2A, TRAF6, CAT, PDE5A, ACPP, MET, BIRC3, NLGN3, RNF31, BECN1, HDAC3, WBP2, CXXC5, ACVR1B, THBS1, P2RY8, CCL5, TP53INP1, P2RY1, SH3BP2, CCL3, CCL2, PTK2B, CSK, ZNF622, SH2B3, SH2B2, SASH1, TBX1, TCF7L2, PDE6H, ANGPT1, SEMA4D, EGF, PDE6G, BAD, FBXL15, SOD1, P2RX7, CD4, P2RX5, P2RX4, VAPA, TRIM39, TNIP2, TSPAN17, ASXL2, BAX, KRAS, PTPN6, TEK, LTBR, FCGR2B, TRIM32]
GO:0009725;response to hormone;4.0;0.5257808277979137;0.5128904138989568;7.033269545535256;21.85620986101781;3.280298637494607;7.315076747364311E-4;0.41775462487096104;[ERRFI1, OXTR, SPARC, UBE3A, NR3C1, ELK1, UBE2L3, AQP1, TXN2, YY1, PPAT, AKT2, NPPA, DAG1, PSPH, PDGFRB, USP8, PAQR6, PRKCI, ENDOG, PAQR7, IGFBP5, SERPINF1, PRKCE, PRKCD, LMO2, RNF40, SFRP1, XRN1, DDIT4, TRIB3, UPRT, MAX, ABCB4, LOC400499, CRHR1, ACACA, RAP1B, SOCS2, TBXA2R, SCAP, CYC1, PPARGC1B, WDTC1, PCK2, ESRRA, EIF2B4, ABCA2, XBP1, EGR2, PNPT1, ABCA3, CAV1, IDH1, MSN, ASNS, DHCR24, CRLS1, NFKB1, BMP6, SOX30, NR4A2, IL6, FER, SP1, TNFSF4, MDM2, SDC1, PAM, EZH2, BTG2, CDKN1A, BTG1, PDE3B, PTEN, WFDC1, PCSK9, AACS, CASP9, CASP8, AIFM1, CASP3, TIMP2, ME1, CTSH, TIMP1, RAB8A, RAB8B, NKX3-1, CTSB, IL10, ABCC2, ANXA1, NCOA6, ITGA2, CAD, CACYBP, SIRT1, NME1, GAL, KIT, CAT, RARA, ACSBG1, PTGER4, PCNA, WBP2, ROCK2, ADCY4, ATP1A1, TFPI, THBS1, ADCY7, RELA, EGFR, PAK1, GNG2, RBBP4, UCP3, PTK2B, CSK, CCL19, RBBP7, NQO1, NOS3, BAD, AGL, CDC5L, AKR1C4, TSHR, CD4, MARS, RAB13, FOSB, CTNNB1, KRAS, GHRL, TEK]
GO:0061049;cell growth involved in cardiac muscle cell development;4.0;0.9326813400603323;0.7163406700301662;9.4949928598676;32.430622850889186;7.697632086000634;0.0010854237611535892;0.6436572628545723;[NPPA, PDLIM5]
GO:0072182;regulation of nephron tubule epithelial cell differentiation;7.0;0.811012628672052;0.7564256795932265;9.387362195675234;88.9858058127024;7.212124270218933;0.002978274838525283;0.7197477358342742;[CTNNB1, CD24]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[CXCL10, APP, TNFSF14, CCL20, DOCK8, CCL5, ADAM10, CD99L2, CCR2]
GO:0001556;oocyte maturation;4.0;1.0;0.75;9.628524252492122;79.08984218955116;6.8867018697843045;0.0026470658418474595;0.6021862538851576;[CCNB1, PTK2B, FBXO5]
GO:0030539;male genitalia development;5.0;1.0;0.7902410118609202;9.628524252492122;66.31594138202881;6.832634648514029;0.002219534877584045;0.639662265535933;[CTNNB1, DHCR24, BMP6, LGR4]
GO:1990138;neuron projection extension;4.0;0.811012628672052;0.655506314336026;9.223059144383958;50.60479478960687;5.69953618377475;0.0016936969402496266;0.5414745454937787;[CYFIP2, ITGB1, NLGN3, PPP3CB, ALCAM, SLC9A6, CDK5, CPNE1, NDN, ULK2, CTNNB1, ULK1, SPG11, C9orf72]
GO:0050848;regulation of calcium-mediated signaling;7.0;0.6664901433067099;0.6841644369105555;8.734706376470026;45.070113835906206;5.266214121163619;0.001508456149618737;0.6202338003175094;[PRNP, CAMK2D, GSTM2, SYK, HOMER2, ATP2B4, CIB1, PKD2, PTBP1, CD4, P2RX5, P2RX4, MAPK7, TMBIM4, RCAN3, CCL3, PTK2B, CALM3, HOMER3, CALM1, CALM2, PDK2]
GO:0031069;hair follicle morphogenesis;4.0;1.0;0.75;9.628524252492122;21.56700107071243;6.518977089658987;7.21828116795923E-4;0.5833807915285978;[WNT10A, IGFBP5, TMEM79, CTNNB1, ATP7A, TGM3]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PDGFRB, PPP1R15A, CDCA2, PPP1R12A, FCRL3, PRKCD, ITGA1, PPP2R5D, PTBP1, PPP1R7, DLC1, SMPD1, CALM3, CALM1, CALM2]
GO:0034333;adherens junction assembly;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;54.6368709792101;6.280566066213989;0.0018286469016826669;0.6443087532925187;[LAMA5, CTTN, ITGA2, RCC2, DLC1, TAOK2, TESK2, PTK2B, CTNNB1, PTPRK, ARHGAP6, SMAD7]
GO:0048096;chromatin-mediated maintenance of transcription;11.0;1.0;0.9324289523296623;9.628524252492122;1311.6223032101445;7.57984905034425;0.043898818105007634;0.8200627852632958;[CTNNB1, ARID1A]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[APP, DCTN2, DCTN1, VPS4B, DCTN3, FHL1, KIF14, BRCA1, MECP2, GPR132, CCNB1, ACTR1A, SIN3A, RAD21, CEP70, TOPBP1, CEP76, MTA3, CLASP1, CDK5RAP3, FANCI, DYNC1H1, ODF2, RCC2, PLK1, DONSON, CDC7, TUBG1, CDC25C, CKAP5, RAB11A, CDC25A, TUBA4A, RINT1, CENPF, RAD51C, CDK6, PKIA, CENPJ, ZFYVE19, TAOK2, CDK2, FGFR1OP, MAPRE1, PAFAH1B1, SDCCAG8]
GO:0120012;intermembrane sphingolipid transfer;7.0;1.0;0.8509193652572005;9.628524252492122;52.07880266361126;9.777073627680469;0.0017430306572715922;0.8509193652572005;[COL4A3BP]
GO:0055072;iron ion homeostasis;9.0;0.811012628672052;0.801746939516315;9.292052015870908;38.23288616879122;5.395046993006588;0.0012796202927058053;0.6721435792979885;[STEAP3, TFRC, NEDD8, BMP6, SOD1, SLC25A28, SLC22A17, MYC, HYAL2, ATP6V0A2, SFXN3, SFXN4, ACO1, B2M, SFXN5, PICALM]
GO:0014047;glutamate secretion;10.0;0.9326813400603323;0.8815816818910864;9.574457031221845;161.52301102016722;6.8867018697843045;0.005406029817572731;0.7674272657460779;[GRM2, NF1, SLC38A2, GLS]
GO:0040014;regulation of multicellular organism growth;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;36.77819272999274;5.557565922504363;0.0012309330124483187;0.5744551915910391;[BBS2, GAMT, APP, MKKS, GDF15, CHD7, SOD1, VIL1, SOCS2, ATRN, NIPBL, SGPL1, GPAM, SH3PXD2B, GHRL]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[GPS1, GPS2, PTPN22, DUSP14, PPP2CA, SPRED1, MAPK7, HYAL2, SMPD1, NUP62, STK38, CDK5RAP3, DUSP4, DUSP5, DUSP2, CAV1, PAQR3, PRKCD, MAPK8IP1, DUSP22, SFRP1, SFRP2, NF1, SPRY1, PTPN6]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CD86, ATF2, APP, SPARC, CD80, LST1, SIRPG, CIB1, PRDM1, COMT, RBPJ, IFIT3, ADORA3, RPS6KA2, MYC, FNTB, TRIM24, IL12A, PIM2, ENPP7, IGFBP5, FBXW7, SERPINF1, TSC2, DICER1, VASH1, SFRP1, TWSG1, SFRP2, KARS, SF1, PTGES, CCL3L1, SDC4, CTBP1, STK4, NDRG2, STK3, TMEM127, SMYD2, NDN, TFAP2A, ZBTB17, PRNP, FZD5, CAV2, CAV1, ZBTB16, IDH2, GLMN, EAF2, IFT122, DHCR24, IL6, BMP2, CDK6, CNOT7, TMEM115, GJB6, NF1, PEMT, CNOT8, CDKN1C, BTG2, CDKN1A, BMPR2, BTG1, TGFB1I1, PTEN, WFDC1, TNFAIP3, PTPRK, PKD2, ING4, FLCN, ING2, ADAMTS1, CASP3, NUP62, TIMP2, CTLA4, JARID2, IFT57, HRAS, EMD, RBM5, HAVCR2, NKX3-1, KLF10, IL10, KLF11, KLF13, IL15, ATPIF1, ITGA1, EMP3, PDCD1LG2, SIRT2, TGFBR1, NME1, GAL, TFDP1, ADORA2A, RAPGEF1, RARA, TAX1BP3, PDE5A, B4GALT7, GAS8, PPARD, BECN1, TOB2, THBS1, TBRG1, PAK1, MNT, RBBP4, TP53INP1, LMNA, MFN2, CCL2, PTK2B, CSK, MSX1, E2F7, CDKN2D, CDKN2B, CDKN2C, NOS3, WDR13, PER2, ITCH, MEIS1, FAP, NFIB, DLC1, IL2RA, CD9, BAX, CTNNB1, MNDA, SPRY1, PTPN6, GHRL, FCGR2B, TRIM32]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CD86, ATF2, TFRC, CCNI, CD80, PDCD6, SIRPG, CCNF, ROGDI, MPL, CIB1, RBPJ, IGF1R, AQP1, TIAL1, PPP1CC, MYC, AKT2, FNTB, SOX8, IL12A, CAPN1, SKP2, MAP3K5, PDGFRB, FBXW4, RPS9, TIPIN, PRKCI, CSNK2A1, IGFBP5, CLEC11A, FLT3LG, ADAM10, PRKCA, RUNX2, ERN1, SFRP1, SFRP2, CCNE2, IL23A, CCNE1, PRKD2, EPHA1, CARD11, SHC1, FOXG1, EBI3, SHOX2, NOLC1, CORO1A, AGER, RTN4, CCNB1, ABL1, SSR1, NCKAP1L, TRPM4, XBP1, CAV2, CDC7, BMP6, CCDC88B, CXCL10, CNOT6, IL6, BMP2, FER, CDK6, CNOT7, SP1, TNFSF4, CDK2, TMEM119, MDM2, NF1, FGFR1OP, CNOT8, MNAT1, CD24, IL7R, CCNJL, ITGB1, CDKN1A, CD40, WDR48, BMPR2, ITGB3, CDCA7L, KIF14, PTEN, TNFAIP3, ARRB1, LAMC1, TNFRSF13C, HOXC10, CXCL5, MECP2, LBH, RBPMS2, CTSH, ITGAV, TIMP1, ATP7A, HRAS, JAK3, CCR2, HLA-DPA1, HAVCR2, NKX3-1, IL10, EIF5A, ANXA1, SYK, SPHK2, RIPK2, IL15, ITGA2, SPHK1, FCRL3, TBC1D8, ARNT, PDCD1LG2, IRAK4, GAB2, SIRT1, TGFBR1, NME1, TRAF6, KIT, RARA, BIRC6, EAPP, ZP3, HBEGF, PPARD, CDC123, HDAC1, PLAG1, DERL2, CRIP2, THBS1, RELA, EGFR, FZR1, PAK1, NRAS, HLA-DMB, CCL5, GCNT2, MFN2, PTK2B, CCL19, IL12RB1, DISC1, MTA3, TBX1, MAP3K3, CD74, EGF, BAD, CNBP, TSHR, PDCL3, CD4, GPAM, IL2RA, CLCF1, HLA-DPB1, AGGF1, CTNNB1, KRAS, PTPN6, GHRL, FAM98A, TEK, FOLR2, SSBP3]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[ATF2, APP, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, IKZF1, IKZF2, RBPJ, ELK1, IKZF3, IKZF4, RPS6KA4, RPS6KA5, MYC, ZC3H12A, DPF2, EPC1, SOX8, SOX6, PKNOX1, IER5, IER2, CDK5RAP3, HOXA5, DDX17, MEF2B, FLT3LG, MED6, RUNX2, RUNX1, SFRP2, IL23A, RFX4, HOXB4, PRKD2, ATF4, PAXIP1, SHOX2, RTF1, ZNF24, HSPH1, RAD21, HLTF, SCAP, HOXC4, ZBED1, PPARGC1B, ZNF143, CREBBP, XBP1, XRCC6, EGR2, JAG1, JUP, FZD5, PBX3, EAF2, NFATC3, NFATC1, ERLIN2, FLI1, SETX, MLLT10, STAG1, ARF4, CD40, GMEB1, SETD3, ELL, HOXC13, BRCA1, AATF, HOXC10, MED12, NIPBL, PPP3CB, HYAL2, MLX, HRAS, TEAD2, GABPA, ZNF485, IL10, NCOA6, RIPK2, TMEM173, PPRC1, SIRT1, SIRT2, GNL3, ZEB2, GAL, MTF2, TFEC, RARA, PPARD, ZNF350, SATB2, GPS2, RELA, EGFR, ARNTL, RXRA, STAT4, PLAGL2, MSX1, ZNF345, ZNF462, CDKN2B, NFYC, MCRS1, NR1H2, ATAD2, GRHL1, PER1, NFIA, NFIB, TTC5, NFIC, PSMC1, FOSB, CTNNB1, CAMK1, AGRN, MIXL1, CRTC2, CCNT1, FHOD1, ARID4A, RORA, YEATS4, UBE3A, PARK7, NR3C1, YY1, SALL2, STK16, NFATC2IP, EP300, HMGN3, ZNF564, LMO2, MITF, PIAS2, ARMCX3, PRPF6, TBL1XR1, MAX, INSIG1, RLF, SUPT6H, BCL2L12, NLRP3, NDN, RIPK1, CYTL1, TFAP2A, ESRRA, ZBTB17, DR1, ZBTB16, RFXANK, NFKB1, BMP6, SMAD7, NFKB2, CDK9, NFKBIA, NR4A2, BCL9, CDK8, CXCL10, IL6, BMP2, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, CIITA, BMPR2, THRB, ONECUT2, THRA, CHD8, CHD7, ARRB1, DDX41, LDB2, PKD2, FLCN, SIN3A, ZNF649, NKX3-1, MKL2, KLF10, KLF13, RBM15, PPP1R12A, PEG3, MKL1, ARNT, SENP2, SAFB, CREB3, SFPQ, TFDP1, RBL1, TFDP2, ELF4, IRF4, THRAP3, TRAF6, EAPP, MET, HDAC3, HDAC1, WBP2, CEBPE, PLAG1, CEBPG, TAF1L, ACVR1B, MAPK7, ABLIM3, P2RY1, MTA2, E2F7, E2F8, TBX1, TCF7L2, CNBP, CDC5L, ARID3B, USF2, POMC, KLF6, MEIS1, TNIP1, TNIP2, TNIP3, ASXL2, TAF7, TAF4, SSBP3]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[TFAP2A, PRNP, ATF2, NQO1, FBXW7, ITGA1, PCSK9, CASP9, CDK5, AIFM1, CASP3, CCL3, NF1, CASP2, BAX, CTNNB1, MAP3K11, ATF4]
GO:0006423;cysteinyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;9.083926447120524;0.006875708083302461;0.8969813732811862;[CARS, CARS2]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[BTG2, LRP1, ITSN1, KIF14, ARRB1, PARK7, PSEN1, ARRB2, CORO1A, MECP2, CLN3, CCL2, PTK2B, SNCB, HRAS, PRKCI, ANGPT1, WFS1, BDNF, NONO, SOD1, NR4A2, ADORA2A, AXL, CLCF1, BAX, KRAS, HYOU1, ADNP, NAIP, CPEB4]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[TBX1, RIPK3, ABL1, CTNNB1, PSEN1, JARID2, TGFBR1, SOD1]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[CYFIP2, APP, BTG2, PIWIL4, EIF4E3, EIF4A3, CASC3, RBM3, EIF4ENIF1, MTRF1, PAIP2B, C1QBP, AKT2, ZC3H12A, EIF5A, UPF1, EIF5B, RPS9, IGFBP5, NCBP1, DAPK1, ITGA2, SECISBP2, MIF4GD, ILF3, DNAJC1, XRN1, RARA, ETF1, EIF4E2, GAPDH, ATF4, PPP1R15A, MTPN, DDX6, KHDRBS1, CDC123, POLDIP3, NOLC1, THBS1, FXR1, ATXN2, RXRA, FXR2, CCL5, MKNK1, TPR, MKNK2, PTK2B, POLR2G, EIF2B4, KLHL25, YTHDF3, EIF2AK3, SAMD4A, SAMD4B, CNOT10, UPF3A, EIF2S1, QKI, PUM2, PPP1CA, PER2, DHFR, TNRC6C, PER1, CNOT6, IL6, CNOT7, CNOT1, CAPRIN1, BCL3, CNOT3, RPS6KB2, ACO1, CNOT8, KBTBD8, LSM14A, EIF4G2, TNRC6A, CPEB4, TNRC6B]
GO:0051145;smooth muscle cell differentiation;5.0;0.7763722522362496;0.6784271379790451;8.85533436425864;21.75937296335754;6.7325511899570465;7.282666309192915E-4;0.6345439928109722;[MKL2, MKL1, EPC1, CTNNB1]
GO:2000538;positive regulation of B cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1000.5321764499969;9.083926447120524;0.03348691152528284;0.8969813732811862;[PTK2B]
GO:0033234;negative regulation of protein sumoylation;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;528.6159484410776;7.379178354882098;0.017692300070855854;0.7926125360964777;[GNL3L, CTNNB1, PARK7, RELA]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[DDX17, TGFB1I1, UBE3A, BRCA1, ARID1A, MED16, PIAS2, MED12, MED30, CCNE1, THRAP3, CTNNB1, FKBP4, NKX3-1]
GO:0010595;positive regulation of endothelial cell migration;9.0;0.8259837884571596;0.8092325194088689;9.488762310116963;298.6320589889849;5.2552850506314295;0.009994946262957053;0.664996147065328;[SCARB1, GPI, CD40, BMPR2, SPARC, ROCK2, ITGB3, PDCD6, CIB1, PIK3C2A, THBS1, TMSB4X, ZC3H12A, ABL1, PTK2B, AAMP, SASH1, MAP3K3, ANXA1, ANGPT1, NOS3, PRKCA, SIRT1, RHOB, P2RX4, SP1, PRKD2, TEK, MET]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[CD40, NCF1, ITGB3, CD80, LRRK1, ARRB2, LRP8, HSPH1, CCL5, ABL1, PTK2B, IL12A, PRNP, CD74, ANGPT1, SEMA4D, SYK, BDNF, EGF, FBXW7, RIPK2, IL15, ADRA2C, CD4, IL6, EHD4, ARL2BP, IL23A, CLCF1, KIT, GHRL, ADNP, CD24, HBEGF]
GO:0051149;positive regulation of muscle cell differentiation;6.0;0.7090535922965819;0.6776471087384355;8.848365694942547;114.55096530066652;5.346256828837156;0.0038339177194376536;0.5965281354432446;[TBX1, CXCL9, IL4R, SETD3, TNFSF14, THRA, MAML1, PARP2, GDF15, SHOX2, FLT3LG, ARRB2, RBPJ, SIRT1, CDH2, KIT, ABL1, SCGB3A1, CTNNB1, CAMK1, TRIM32]
GO:0016358;dendrite development;6.0;0.8259837884571596;0.7361122068187242;9.260799472366804;32.63417926892749;6.343086423195323;0.0010922366112764486;0.647506047256038;[MECP2, APP, GRIN3A, MAP1S, LST1, GHRL, SCARF1]
GO:0048669;collateral sprouting in absence of injury;5.0;1.0;0.7902410118609202;9.628524252492122;51.7034070782764;9.083926447120524;0.0017304665048645269;0.7547934328124444;[APP]
GO:0006310;DNA recombination;7.0;0.612588685250814;0.6572137078826075;8.529911963824013;149.0421272461911;4.488806596985934;0.0049883058697239;0.5804771433779154;[FEN1, WDR48, DCLRE1C, HMGB3, BRCA1, SMC6, RBPJ, YY1, POLB, NIPBL, EXO1, NFRKB, ENDOG, FBXO18, NCOA6, SWAP70, NSMCE2, WRNIP1, TSN, MORF4L1, SFPQ, RAD51C, MSH3, PAXIP1, TCF7, UNG, RAD51AP1, TFPT, WRN, RNF138, RAD21, RAD54L, EXOSC3, POLQ, KLHDC3, XRCC6, XRCC5, POLM, NONO, MCRS1, GINS4, APEX2, CDC7, FANCB, AICDA, SETX, RAD50, RAD51, RFWD3, ERCC1]
GO:0048668;collateral sprouting;4.0;0.8653626801206646;0.6826813400603323;9.310070521373587;50.60479478960687;7.697632086000634;0.0016936969402496266;0.6436572628545723;[APP, ZEB2, BDNF, ABL1]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[APP, NCF1, CIB1, IGF1R, RASSF2, CDH2, ZC3H12A, ARL6IP5, MAP3K9, PDE8A, EPHB4, MAP3K5, PDGFRB, FBXW7, PRKCE, PRKCA, MAPK8IP3, MAPK8IP1, ERN1, KARS, MADD, PRKD2, EPHA1, CCL3L1, SHC1, PSEN1, AGER, STK3, RAP1B, RAP1A, ABL1, DVL3, RIPK1, FZD5, CAV2, IL6, BMP2, STK24, CD24, MAP3K11, EZH2, CD40, PTEN, PTPN22, ARRB1, ARRB2, PIK3CG, AKAP13, TIMP2, NPTN, ITGAV, HRAS, HAVCR2, FGA, DUSP5, MAP4K2, DBNL, KSR1, SYK, RIPK2, FCRL3, FGG, ITGA1, ADRA2C, TGFBR1, DUSP22, ZEB2, TRAF6, KIT, RAPGEF1, PDE5A, MET, ARHGEF5, AVPI1, THBS1, EGFR, PAK1, CCL5, P2RY1, CCL3, GCNT2, CCL2, PTK2B, CSK, ZNF622, CCL19, SASH1, MAP4K3, TBX1, MAP3K3, CD74, MAP3K1, PDE6H, ANGPT1, CCL20, RYK, EGF, PDE6G, GDF15, GPR55, SORBS3, SOD1, P2RX7, CD4, AXL, TAOK2, CTNNB1, KRAS, GHRL, TEK, LTBR, FCGR2B]
GO:0043534;blood vessel endothelial cell migration;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;26.070480469920426;6.599019797332524;8.725555194190899E-4;0.712474179321389;[ITGB1, SCARB1, MYH9, PTK2B, EPHB4]
GO:1902748;positive regulation of lens fiber cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;233.0352950572082;9.777073627680469;0.007799481607415263;0.8509193652572005;[ZEB2]
GO:1903829;positive regulation of cellular protein localization;6.0;0.5960880403619941;0.6211643327711416;7.795942788743812;40.8677261891161;4.050225880093272;0.0013678060169840123;0.5302490524528797;[ITGB1, USP36, NUMA1, YWHAB, ITGB2, UBE2D3, CIB1, PARK7, ABCA12, BICD1, BBC3, UBE2L3, NPEPPS, UBL5, NIPBL, CASP8, HYAL2, AKT2, NUP62, ZC3H12A, NPTN, GTSE1, HRAS, EMD, CDK5RAP3, PRKCI, FCER1G, DTX3L, FBXW7, PRKCE, PRKCD, ACSL3, ANK3, TMEM173, YWHAZ, GNL3, CLIP3, TFDP1, TFDP2, RER1, RUFY3, RHOU, GAS8, RNF31, HDAC3, LRP1, EPB41, ROCK2, PSEN1, UBE2J2, TM9SF4, EGFR, RTN4, PAK1, PARD6A, ABLIM3, BAG3, TPR, UBR5, VPS11, TP53BP2, LRIG2, ECT2, BID, SPTBN1, PRNP, TCF7L2, TMEM30A, JUP, FZD5, TMEM30B, BAD, EDEM1, MCRS1, PLK1, EIF2AK3, MSN, NDC80, RAB11A, SSH1, VIL1, CCDC88A, CYLD, GNL3L, CDK5, MDM2, CAMK1]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CAMK2D, CXCL9, GSTM2, PRKCE, CHD7, PKD2, CORO1A, CXCL10, CXCL11, ABL1, BAX, PTK2B, CALM3, PTPN6, CALM1, CALM2, NTSR1, ATG5]
GO:0030513;positive regulation of BMP signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.571365838652174;514.640204837359;6.311337724880743;0.017224544509792043;0.770882417347765;[TWSG1, BMPR2, NUMA1, FBXL15, MSX1, RBPJ, RNF165]
GO:0030997;regulation of centriole-centriole cohesion;9.0;0.8933024483968273;0.8428918493787028;9.474373572664863;54.56804827344474;8.67846133901236;0.0018263434676571142;0.8400575416471059;[CTNNB1]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[SETX, TBX1, SERPINF1, TWF2, RARA, PTK2B, ZNF35, TEAD2, AQP1]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[LAMA5, BMP2, MYC, CTNNB1, DCHS1, PKD2]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[APP, TRIM6, EGF, RIPK2, SPHK1, PLK1, PRKAG2, CALM3, CALM1, CALM2]
GO:0042976;activation of Janus kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1439.1116520623075;8.16763571524637;0.04816577187812465;0.8658135829017477;[PTK2B]
GO:0034394;protein localization to cell surface;5.0;1.0;0.7902410118609202;9.628524252492122;29.829169826127035;6.686031174322154;9.983554695705216E-4;0.6321649570480018;[PIGU, ANGPT1, CTNNB1, PTPRK, FBLN5]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[CCNB1, RBPJ]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[APP, LRP1, EPB41, ARRB1, PARK7, PSEN1, STK4, STK3, PPP2CA, PPP2CB, ABL1, EP300, B2M, DACT1, TCF7L2, DTX3L, BDNF, RIPK2, CAV1, PLCL2, TMEM173, BMP2, GNL3L, CDK5, MAPRE3, TRIB3, MAPRE1]
GO:0006120;mitochondrial electron transport, NADH to ubiquinone;6.0;1.0;0.8231203125901445;9.628524252492122;32.64917349834284;5.9928839937622085;0.0010927384546410499;0.6295966787287501;[NDUFA7, NDUFB7, NDUFS8, NDUFB10, NDUFS7, NDUFB6, NDUFS6, NDUFA10, COQ9, NDUFV3, NDUFAF1]
GO:0060844;arterial endothelial cell fate commitment;7.0;1.0;0.8509193652572005;9.628524252492122;24.429201951642014;9.777073627680469;8.176234044670794E-4;0.8509193652572005;[RBPJ]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[TCERG1, ATF2, ZNF175, CCNK, CCNT1, CCNH, ZNF292, ARID4A, NR3C1, ELK1, IKZF3, SALL2, MYC, STK16, TRIM24, EP300, PKNOX1, NFRKB, IER2, HOXA5, GTF2I, MEF2B, LMO2, ZBTB32, MITF, RUNX1, RFX4, ATF4, MAX, RTF1, RPAP1, ZNF24, SUPT6H, GTF2E2, TAF5L, DEAF1, RAD21, HLTF, HIVEP1, HOXC4, ZBED1, NDN, HIVEP2, TFAP2A, ZBTB17, ZNF143, XBP1, EGR2, INTS3, PBX3, EAF2, NFATC3, NFXL1, NFATC1, FLI1, NFKB1, NFKB2, CDK9, STAG1, TFCP2, COPS5, SP1, MAFF, NFE2L3, PIR, INTS4, INTS7, INTS6, MNAT1, ZNF136, INTS8, NFE2L1, GMEB1, BMPR2, ONECUT2, ELL, THRA, TGFB1I1, INTS10, ARRB1, HOXC13, BRCA1, ARRB2, MED16, AFF4, HOXC10, SNAPC5, HYAL2, ZNF768, GABPA, MKL2, KLF10, KLF11, TBP, KLF13, NCBP1, TSC22D1, MKL1, ARNT, SIRT1, SUPT3H, CREB3, ZEB2, NCOR1, TFDP1, TFDP2, ELF4, IRF4, NFX1, TFEC, MED20, ZNF516, LCOR, GTF2A1, WBP2, CEBPE, PLAG1, SATB2, CEBPG, MLLT1, TAF1L, RELA, ARNTL, MNT, POLR2B, TAF1A, POLR2E, PLAGL2, POLR2G, MSX1, POLR2I, ZNF345, POLR2K, TCFL5, POLR2J3, TAF15, TAF12, NFYA, TAF13, NFYC, CDC5L, ARID3B, DEK, GRHL1, USF2, GTF2H4, GFI1B, KLF6, MEIS1, NFIA, NFIB, NFIC, TAF7, FOSB, CTNNB1, TAF5, TAF4, SSBP3, MIXL1]
GO:0008542;visual learning;8.0;1.0;0.875;9.628524252492122;51.65827414420079;5.970411137910149;0.00172895594617802;0.6803271032452366;[ITGB1, NLGN3, APP, DDHD2, CTNS, RIC8A, MECP2, CDK5, HRH2, DEAF1, KIT, NF1, NPTN, KRAS]
GO:0043267;negative regulation of potassium ion transport;8.0;0.7436939687323844;0.7468469843661922;9.0306872517365;68.61495707395616;6.444869117505266;0.00229648086381306;0.7045909063862833;[KCNE3, NOS3, CAV1, PTEN, PTK2B, OXSR1, ANK3, ATF4]
GO:1903204;negative regulation of oxidative stress-induced neuron death;9.0;0.8653626801206646;0.8289219652406215;9.582004236857228;363.9833276048854;6.8867018697843045;0.012182194411207908;0.7484268790654467;[FZD1, IL10, NONO, CTNNB1, PARK7, ATF4]
GO:0043149;stress fiber assembly;8.0;1.0;0.875;9.628524252492122;75.13737719114397;7.292166977892469;0.00251478039533833;0.747921758369865;[ITGB5, PTK2B, ARRB1, PHACTR1, TNFAIP1]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[GTF2A1, CDKN1A, THRB, THRA, MAML1, CCNH, RORA, TAF1L, ZNF45, NR3C1, MED16, RBPJ, GTF2E2, MED12, RXRA, MED30, POLR2B, NPPA, POLR2E, POLR2G, POLR2I, TEAD2, POLR2K, GTF2I, ESRRA, CREBBP, TBP, TAF15, TAF12, TAF13, NR1H2, GTF2H4, MED6, RUNX2, CDK9, NR4A2, CDK8, THRAP3, MED20, RARA, TAF7, BAX, TAF5, MNAT1, TAF4, PPARD]
GO:0048715;negative regulation of oligodendrocyte differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;472.5210628944727;7.292166977892469;0.015814854733730403;0.7881627702307852;[NF1, CTNNB1]
GO:0150003;regulation of spontaneous synaptic transmission;7.0;0.8653626801206646;0.7836007053175329;9.405380701177911;30.61939422688933;8.16763571524637;0.001024803569108247;0.7686126355688037;[APP, AGER]
GO:0009755;hormone-mediated signaling pathway;5.0;0.6519675769143192;0.6162248003180799;7.98629651723503;23.17027026302992;4.61801832846594;7.75488093814194E-4;0.5264066839384828;[THRB, THRA, WBP2, TGFB1I1, RORA, UBE3A, BRCA1, NR3C1, MED16, ADIPOR2, MED12, RXRA, MED30, NUP62, UBR5, PPARGC1B, NKX3-1, DDX17, ESRRA, PAQR6, EGLN2, PAQR7, NCOA6, NR1H2, DDX54, SAFB, ARID1A, TSHR, PIAS2, NR4A2, LATS2, CCNE1, THRAP3, NEDD4, RARA, TAF7, CTNNB1, GHRL, FKBP4, LGR4, PPARD]
GO:0023021;termination of signal transduction;7.0;0.8653626801206646;0.7836007053175329;9.434368238051164;144.8699869040881;8.67846133901236;0.004848668087156246;0.7947362817240173;[SMPD1, PRKCD]
GO:0051563;smooth endoplasmic reticulum calcium ion homeostasis;11.0;0.8933024483968273;0.8790801765280758;9.533214072687796;289.7905246169981;9.083926447120524;0.009699028064390986;0.8969813732811862;[APP, PSEN1]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[EIF2B4, TCF7L2, XBP1, ENDOG, BAD, SERPINF1, PTEN, LPL, THBS1, AACS, NME1, TXN2, ERN1, GYS1, RAP1A, GPAM, SIN3A, CASP3, GJB6, PTK2B, PCK2, PPARD]
GO:0002315;marginal zone B cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;149.8071031872776;7.57984905034425;0.005013908926038414;0.7838744581139225;[DOCK11, BCL3, PTK2B]
GO:0002437;inflammatory response to antigenic stimulus;5.0;0.7369933605727446;0.6587376921472925;8.866384200445225;27.85633247086267;6.343086423195323;9.323263787281718E-4;0.6146267465268138;[IL2RA, IL5RA, RBPJ]
GO:0097324;melanocyte migration;7.0;1.0;0.8509193652572005;9.628524252492122;24.971868181253015;9.083926447120524;8.357859548042604E-4;0.8154717862087246;[ZEB2, KIT]
GO:0048169;regulation of long-term neuronal synaptic plasticity;9.0;0.8933024483968273;0.8428918493787028;9.461470167828956;42.75619717690252;6.481236761676141;0.0014310114414316764;0.7276913745807394;[APP, KIT, NF1, NPTN, KRAS, HRAS, RAB11A, RAB8A]
GO:2000310;regulation of NMDA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.8867018697843045;0.006718796083723233;0.7484268790654467;[NLGN3, APP, DAPK1, PTK2B, CAPN1]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[MACF1, BMPR2, GDI1, CPNE5, SHOX2, TWF2, PSEN1, TRAK1, LRP8, RTN4, RAB21, NCKIPSD, PAK1, RAP1A, NPTN, DVL3, PTK2B, SCARF1, MARK2, ARSB, FZD1, ACTR2, PRKCI, TMEM30A, CAMK1D, SEMA4D, TNFRSF12A, BDNF, SERPINF1, FBXO38, RAB11A, NME1, SETX, ZEB2, FES, RUFY3, CAPRIN1, ITPKA, RAPGEF1, CAMK1, ADNP, MEGF8, PAFAH1B1, EZH2]
GO:0060291;long-term synaptic potentiation;8.0;1.0;0.875;9.628524252492122;145.7697243391103;5.948432231191374;0.004878781489395318;0.6792031009335148;[SLC8A3, NLGN3, MECP2, PTEN, NPTN, PTK2B]
GO:0060292;long term synaptic depression;8.0;1.0;0.875;9.628524252492122;145.80791725818347;7.004484905440688;0.004880059772025301;0.7332096838060964;[PTEN, PTK2B, ABHD6]
GO:0035235;ionotropic glutamate receptor signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.310070521373587;27.195621953761602;6.558197802812269;9.102129923216596E-4;0.6863059058804069;[CLN3, APP, GRIN3A, PTK2B, SULT1A3, CPEB4]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[LAMA5, CTTN, ITGA2, RCC2, DLC1, TAOK2, TESK2, PTK2B, PTPRK, ARHGAP6]
GO:0035115;embryonic forelimb morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;58.806290969860136;6.343086423195323;0.001968193636535348;0.647506047256038;[TFAP2A, NIPBL, SHOX2, ALX3, IFT122, CTNNB1, MSX1, ZNF358, RUNX2]
GO:0035116;embryonic hindlimb morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;58.806290969860136;6.444869117505266;0.001968193636535348;0.6527112189764278;[ZBTB16, CHD7, ALX3, CTNNB1, MSX1]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[MECP2, APP, CCNB1, RAD51C, SIN3A, RCC2, VPS4B, CDC7, CDC25C, MTA3, RAB11A, CDC25A]
GO:0061001;regulation of dendritic spine morphogenesis;11.0;0.8933024483968273;0.8790801765280758;9.548481544818586;263.40314350006116;6.166155715036245;0.00881586616550832;0.747766442352181;[DNM3, NLGN3, ACTR2, CDK5, CAPRIN1, CFL1, ITPKA, PTEN, PDLIM5, LRP8, PAFAH1B1]
GO:0035112;genitalia morphogenesis;4.0;0.7586651285174919;0.629332564258746;8.85533436425864;33.85048388619649;7.138016298065211;0.0011329452322133542;0.6150384854347593;[NIPBL, SYCP2, TCF7, CTNNB1]
GO:0007223;Wnt signaling pathway, calcium modulating pathway;9.0;1.0;0.896240625180289;9.628524252492122;33.206889128170424;6.250713103064308;0.001111404694859899;0.7159023839588838;[TCF7L2, FZD5, FZD6, NFATC1, TNRC6C, PPP3CB, GNG2, GNAT2, CTNNB1, CALM1, PLCB2, TNRC6A, TNRC6B]
GO:1902004;positive regulation of amyloid-beta formation;8.0;1.0;0.875;9.628524252492122;442.71613466832366;7.474488534686424;0.01481731060869512;0.7572456912631272;[APP, ROCK2, PICALM]
GO:0007221;positive regulation of transcription of Notch receptor target;12.0;1.0;0.9481203125901445;9.628524252492122;1467.8987330058965;6.8867018697843045;0.04912924957061573;0.8003065664753022;[CREBBP, RBM15, MAML1, EP300, RBPJ]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[ANKRD17, CXCL6, SPON2, SEH1L, HIST1H2BJ, PPP1R11, CEBPE, SHC1, DEFB1, DEFB123, NLRC4, PLA2G6, RBPJ, LYST, COCH, NLRP3, IL12A, HAVCR2, IL10, FGA, FCER1G, SYK, CCL20, RIPK2, PRKCD, ISG15, RNASE3, PPBP, LYZ, MR1, AICDA, P2RX7, SELP, CD4, IL6, IL23A, BCL3, S100A8, HIST1H2BC]
GO:0006378;mRNA polyadenylation;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;472.4435102429282;6.250713103064308;0.015812259116276064;0.734902770639515;[APP, AHCYL1, CPSF6, PNPT1, PCF11, CPSF3, PAPOLG, CPSF2, SSU72, PAPOLA, GRSF1]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[ATF2, ZNF175, RPL3, RNH1, ZNF174, RBPJ, MYC, ZC3H12A, DIP2A, DDX17, ZNF282, DAPK1, SERPINF1, ZNF12, DICER1, HCFC2, SND1, EID1, HOXB4, SERPING1, RPL29, RPL28, ATF4, CTBP1, MEPCE, SHOX2, BAZ2A, ZNF24, GLG1, MTDH, HESX1, PPARGC1B, FZD1, HEXIM2, CREBBP, ZNF263, ZNF140, H3F3A, PLK1, EIF2AK3, NFATC3, UPF3A, DHFR, QARS, PKIA, TNFSF4, PKIG, ZNF136, EZH2, CPEB4, CDKN1C, ZNF254, BTG2, CDKN1A, SMG1, TCF25, PHF1, ID2B, TFCP2L1, SMG5, ING4, MECP2, NIPBL, TRIM6, ANXA7, CIC, JARID2, HAVCR2, UPF2, ZNF485, UPF1, HELLS, HSBP1, SIRT4, SIRT7, SIRT1, SIRT2, AES, NCOR2, ZEB2, NCOR1, PTRH2, MTF2, RARA, PPARD, ZNF350, GPS2, BCLAF1, NSD1, ZNF589, ZNF345, RPL19, YTHDF3, NR1H2, SAMD4A, SAMD4B, GATAD2A, CENPF, FABP4, NFIA, NFIB, NFIC, FOSB, LGR4, LIMS1, CCNT1, NAB1, GMNN, UBE2D3, UBP1, ZBTB20, CASC3, PARK7, YY1, EIF4ENIF1, SALL2, ZNF564, TLE4, RPS9, IGFBP5, RPS7, ZBTB32, SARS, RPSA, MITF, RNF40, OLFM1, MORF4L1, ILF3, MRTO4, ZNF318, ADNP, KHDRBS1, MAGEL2, MAX, SHC1, BCL2L12, BAG3, TPR, ZKSCAN3, SMYD2, WDTC1, ESRRA, DR1, WFS1, ZBTB16, LSM5, NFKB1, QKI, NFKB2, CDK9, CNOT4, CNOT6, DAB2, CNOT7, CDK5, YEATS2, CNOT1, SP3, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, MDM2, CNOT8, CIITA, PIWIL4, PTPN22, PTBP1, SIN3A, ZNF649, HIF1AN, YAF2, NKX3-1, CR1, PEG3, RFC1, DIS3, PAPD4, ZFP90, DUSP22, TFDP2, TRAF6, RPL37A, LCOR, ETF1, BIRC6, EIF4E2, GAPDH, BIRC3, HDAC3, HDAC1, PLAG1, NLRC4, CXXC5, LRP8, DNAJB1, RBBP4, U2AF2, DNAJB5, DNAJB4, TP53INP1, CCL3, SAP18, POLR2G, RBBP7, E2F6, E2F7, E2F8, IRX1, RNF20, SEMA4D, CNBP, RPL23A, PNRC1, PNRC2, TNRC6C, TNRC6A, TRIM33, TNRC6B, TCERG1, APP, GFI1, EIF4A3, PPP2R2A, IKZF1, IKZF2, IKZF4, RPS15, RPS6KA5, SAP130, DPF2, TRIM24, CPNE1, EPC1, SOX8, TRIM27, SOX6, SFMBT1, SLC35C2, SFMBT2, RUNX2, THAP1, RUNX1, SFRP1, SFRP2, XRN1, THAP7, TRIB3, NAIP, FOXG1, RTF1, FXR1, FXR2, DHX34, HIVEP1, A2M, BBS2, XRCC6, XRCC5, BCL11A, RPS27, DCP1A, RCOR3, RBAK, CC2D1B, DCP1B, HBS1L, SUV39H1, NKAP, OTUD7B, BRCA1, PTPRK, C1QBP, SUFU, UIMC1, MLX, HRAS, GABPA, TSC22D4, HBZ, PRMT2, TSC22D3, PPHLN1, NME1, NFX1, CSDE1, DEPDC1, DCP2, SATB2, PRICKLE1, RELA, ARNTL, PPP2CA, MNT, RXRA, MSX1, EXOSC3, DCPS, NFYC, SORBS3, PEX14, PER2, PER1, GFI1B, HIST3H2A, NEDD4, CTNNB1, ZNF354A, PRDM5, ARID4A, PRDM1, UBE2Z, NR3C1, PAIP2B, WWC3, EP300, HIST1H2AG, FBXW11, ERN1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, MYADM, PPID, DDX6, TCF7, PSEN1, SUPT6H, CCNB1, NLRP7, DEAF1, SUDS3, BPTF, TFAP2A, PRNP, CBX6, UBE2I, PNPT1, CBX4, CBX3, NONO, CAV1, PHF12, NFXL1, CNOT10, HELZ, EIF2S1, BMP6, DNAJC17, SMAD7, NR4A2, BMP2, PAN3, CAPRIN1, SKIV2L, PHF19, PICALM, USP36, THRB, THRA, YWHAB, CHD8, LDB2, FLCN, HIST1H1D, LRRFIP1, DACT1, KLF10, KLF11, KLF12, MKKS, H2AFY, NCBP1, EED, ARID1A, SFPQ, RBL1, THRAP3, EAPP, ZP3, MCPH1, ACVR1B, THBS1, MTA2, MTA3, ZNF189, TCFL5, SPEN, ATF7IP, TCF7L2, TAF7]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[CSTA, ST14, ANXA1, JAG1, CASP3, STK4, RBPJ, LCE1F, TGM3]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[SPEN, GALNT11, APP, CREBBP, JAG1, MAML1, NOTCH2NL, PSEN2, NKAP, ADAM10, DTX2, PSEN1, RBPJ, MIB1, ITCH, BMP2, PERP, MYC, IL2RA, EP300, HES4]
GO:0060716;labyrinthine layer blood vessel development;5.0;1.0;0.7902410118609202;9.628524252492122;85.12843743852892;6.781341354126479;0.0028491721904478507;0.6370391240755715;[NSDHL, FZD5, TMED2, VASH1, RBPJ]
GO:0051694;pointed-end actin filament capping;13.0;1.0;0.9625549647676366;9.628524252492122;827.5885363368888;7.8311634786251565;0.027698643529868262;0.8630410292508717;[TMOD3]
GO:0043162;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;9.0;1.0;0.896240625180289;9.628524252492122;157.5507831317809;7.004484905440688;0.005273082924921447;0.7544503089863854;[VPS4B, NEDD4, UBAP1, VPS37A]
GO:0051571;positive regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.004484905440688;0.026910571697265715;0.7906386361357586;[PAXIP1, CTNNB1, BRCA1, RTF1]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[P2RX7, HLA-H, IL23A, STX7, HLA-C, IL12A, HLA-A, HLA-F, IL12RB1, B2M, CD1A]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[SMG1, CAMK2D, MAST4, MAST3, ROCK2, STK4, RPS6KA4, CCNB1, RPS6KA5, MAPK7, CAMKV, MKNK1, AKT2, STK38, MKNK2, PHKG2, STK38L, RIPK1, IKBKE, MARK2, PRKCI, CAMK1D, SYK, PRKCE, NEK6, PRKCD, PLK1, EIF2AK3, CDC7, VRK1, PRKCA, VRK2, MASTL, TGFBR1, MAPK13, CLK1, ERN1, LATS2, CDK5, CAMK4, CDK2, ULK1, PKN2, PRKD2, CAMK1, CSNK1G2, CSNK1G1]
GO:0048170;positive regulation of long-term neuronal synaptic plasticity;10.0;1.0;0.9152410118609203;9.628524252492122;315.9495864907144;8.16763571524637;0.010574548323677036;0.8329342821725234;[KIT, NPTN]
GO:0060066;oviduct development;4.0;1.0;0.75;9.628524252492122;49.55861996907746;8.67846133901236;0.0016586824105027187;0.6938169164668168;[CTNNB1]
GO:0008088;axo-dendritic transport;7.0;0.6799073451904818;0.6908730378524415;8.935377071932177;68.32943527352603;5.769740442447999;0.002286924706105601;0.6459841598043611;[APP, TRAK1, SOD1, RAB21, FXR1, AP3M2, AP3M1, SPAST, FXR2, KIF3B, BLOC1S1, KIF4A, AP3S2, SPG11, PAFAH1B1]
GO:0061154;endothelial tube morphogenesis;6.0;0.8259837884571596;0.7361122068187242;9.310070521373587;48.80114014223953;7.379178354882098;0.0016333302423860384;0.7004918368257019;[STARD13, CTNNB1, CCM2, PRKD2, RBPJ, RHOB]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[APP, PNPT1, SPARC, IGFBP5, ITPR2, PKD2, RELA, PIK3CG, NME1, AQP1, RAP1B, SLC8A3, THBD, PER1, RAP1A, RAPGEF1, SDC1, FOSB, PTK2B, TEK, PPARGC1B]
GO:0003198;epithelial to mesenchymal transition involved in endocardial cushion formation;7.0;1.0;0.8509193652572005;9.628524252492122;26.141399598032546;7.379178354882098;8.749291188139309E-4;0.728290889492758;[MSX1, RBPJ]
GO:1904798;positive regulation of core promoter binding;7.0;1.0;0.8509193652572005;9.628524252492122;62.59990527316089;7.9853141584524145;0.002095162493235609;0.7592887026755414;[CTNNB1]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[APP, OXTR, CCNK, GMFB, MAML1, CCNH, TESK2, MYLK, RPS6KA4, RPS6KA5, RASSF2, RPS6KA2, MYC, AKT2, TRIM24, CPNE3, TRIM27, EPHB4, PDK2, PDK1, PRKCI, CSNK2A1, DAPK1, PRKCE, PAQR3, PRKCD, PRKCA, PRKAB1, MAPK8IP1, BCR, KARS, PRKD3, ULK2, TRIB3, ULK1, PRKD2, EPHA1, CTBP1, NUAK1, STK38L, TRPM7, TRPM6, SULT1A3, SPTBN1, PLK1, EIF2AK3, CDC7, ERLIN2, SETX, CALM1, SMG1, FASTKD1, CAB39L, PRKAG1, PRKAG2, AATK, AKAP13, PPP3CB, ZMYM2, CAMKV, FASTK, PBK, CTSH, HRAS, JAK3, IKBKE, DUSP5, MAP4K2, RIPK3, SYK, MMD, RIPK2, IL15, TYK2, GFRA2, CIT, GAK, ITPKB, PDIK1L, KIT, ITPKA, FASTKD5, RARA, FAM20C, TLR7, STK40, HBEGF, ARHGEF6, PTGER4, GPS1, GPS2, EGFR, PAK1, NRAS, MAP4K3, MAP3K3, MAP3K1, GLYCTK, GTF2H4, AXL, CAMK4, TAOK2, PKN2, CAMK1, CCNT1, IL5RA, BUB1B, STK19, IGF1R, GRAP2, CFL1, STK16, NEK1, PIM3, PIM2, MAP3K9, MAP3K5, PDGFRB, KCNH3, FBXW11, ADAM10, VRK1, VRK2, ERN1, ILF3, CCNE1, CSNK1G2, CSNK1G1, SHC1, PKMYT1, STK4, RASGRP4, STK3, RASGRP3, CCNB1, STK35, STK38, GRK6, ABL1, MBP, RIPK1, MARK2, NEK6, CLK4, EIF2S1, CLK3, NFKB1, CLK2, SMAD7, CLK1, CDK9, CDK8, BMP2, FER, PAN3, CDK6, CDK5, STK24, PTPRA, FES, CDK2, NF1, FGFR1OP, MNAT1, FGF13, MAP3K11, BMPR2, MAST4, MAST3, YWHAB, LRRK1, PIK3CG, SPRED1, RASGEF1A, TLK1, ITGAV, CLEC1B, SCYL1, CAMK1D, KSR1, SH2D3A, CAD, SH2D3C, OXSR1, IRAK4, MASTL, SPTB, TGFBR1, LATS2, TRAF6, PIK3C3, BIRC6, MET, CAMK2D, ROCK2, TAF1L, IL2RG, ACVR1B, MAPK7, PABPN1, RPS6KC1, CCL5, MKNK1, MKNK2, PHKG2, CCL3, CCL2, PTK2B, NCAM1, CSK, ANGPT1, EGF, MAPK13, P2RX7, SNRK, WEE1, TNIP2, IL2RA, RPS6KB2, CCM2, KRAS, PTPN6, TEK]
GO:0060742;epithelial cell differentiation involved in prostate gland development;5.0;0.8653626801206646;0.7229223519212526;9.310070521373587;43.82069192109257;7.474488534686424;0.0014666391225366452;0.6724867031240476;[RXRA, CTNNB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ATF2, ZNF175, ZNF174, GFI1, IKZF2, RBPJ, MYC, SAP130, EPC1, SOX8, TRIM27, SOX6, DICER1, HCFC2, THAP1, RUNX1, EID1, HOXB4, TRIB3, CTBP1, FOXG1, MEPCE, SHOX2, RTF1, MTDH, HIVEP1, HESX1, HEXIM2, CREBBP, ZNF263, ZNF140, BCL11A, PLK1, NFATC3, PKIA, RCOR3, PKIG, ZNF136, EZH2, CC2D1B, ZNF254, BTG2, TCF25, SUV39H1, NKAP, OTUD7B, TFCP2L1, MECP2, NIPBL, C1QBP, SUFU, MLX, CIC, JARID2, GABPA, HBZ, HSBP1, TSC22D3, SIRT7, SIRT1, SIRT2, AES, NCOR2, ZEB2, NCOR1, NFX1, MTF2, RARA, PPARD, ZNF350, SATB2, GPS2, RELA, MNT, RXRA, NSD1, MSX1, ZNF589, ZNF345, NR1H2, SORBS3, GATAD2A, PER2, PER1, GFI1B, NFIA, NFIB, NFIC, NEDD4, FOSB, CTNNB1, ZNF354A, UBE2D3, PRDM5, ZBTB20, PRDM1, NR3C1, YY1, SALL2, WWC3, EP300, ZNF564, TLE4, ZBTB32, SARS, MITF, BRMS1, TBL1XR1, CCNE1, TIMELESS, PPID, MAX, TCF7, PSEN1, BAG3, DEAF1, TPR, ZKSCAN3, SMYD2, SUDS3, BPTF, WDTC1, TFAP2A, ESRRA, DR1, CBX6, UBE2I, CBX4, WFS1, CAV1, ZBTB16, PHF12, NFXL1, NFKB1, BMP6, DNAJC17, SMAD7, NFKB2, NR4A2, BMP2, CNOT7, YEATS2, CNOT1, SP3, CDK2, NFE2L3, MDM2, CIITA, THRB, THRA, CHD8, LDB2, FLCN, SIN3A, ZNF649, HIST1H1D, LRRFIP1, HIF1AN, DACT1, KLF10, KLF11, KLF12, PEG3, RFC1, H2AFY, EED, ARID1A, ZFP90, DUSP22, SFPQ, RBL1, TRAF6, LCOR, EAPP, MCPH1, HDAC3, HDAC1, CXXC5, LRP8, DNAJB1, DNAJB5, DNAJB4, RBBP7, MTA2, E2F6, MTA3, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, ATF7IP, TCF7L2, SEMA4D, CNBP, TAF7, TRIM33]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[OLFM1, BMP2, DAB2, TGFB1I1, GCNT2, CTNNB1, TGFBR1, EZH2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[SPARC, PTEN, ITPR2, ADCY7, AACS, POLB, EEF1B2, CASP8, TBXA2R, KCNMB1, TP53INP1, SDF4, PTK2B, ACTR2, NQO1, G6PD, GSN, SETDB1, BAD, PRKCE, SOD1, GRIN3A, CAT, RARA, PEMT, S100A8]
GO:0045596;negative regulation of cell differentiation;5.0;0.44223782556504454;0.5113599246434426;6.502738850689933;82.78823984741369;3.2727854541438237;0.0027708478831143203;0.4576114121859235;[APP, GFI1, CIB1, RORA, RBPJ, CXCL14, EIF4ENIF1, MYC, ZC3H12A, SOX8, SOX6, B2M, HOXA5, SEMA6B, MYLIP, G6PD, IL4R, IGFBP5, FBXW7, PAQR3, OMG, THOC2, DICER1, RC3H2, RUNX1, SFRP1, TWSG1, SFRP2, RUFY3, ULK2, TRIB3, FKBP4, ANKRD17, CETP, DDX6, FOXG1, INSIG1, PSEN1, RTN4, SRGAP2, TRPM4, SOCS5, XBP1, JAG1, BDNF, CAV1, RCC2, ZBTB16, IDH2, NFATC3, NFATC1, HOOK3, SMAD7, NFKBIA, CYLD, CXCL10, IL6, BMP2, CDK6, COL5A1, CDK5, TNFSF4, MDM2, NF1, FGF13, EZH2, ITGB1, GDI1, ITGB3, TGFB1I1, PTEN, ID2B, MECP2, PTBP1, TRIM6, LBH, SUFU, RBPMS2, CTLA4, ITGAV, JAK3, GABPA, ZNF365, KLF13, RBM15, ANXA1, SIRT1, SIRT2, TGFBR1, MED28, NME1, GAK, ITPKB, DNM3, GAL, CTDSP1, GORASP1, RARA, PAFAH1B1, PPARD, NLGN3, SEMA3C, LRP1, GPS2, RNF6, PRICKLE1, TOB2, EGFR, ARNTL, PPP2CA, PAK1, TP53INP1, CCL3, PTK2B, LRIG2, MSX1, TBX1, P2RY12, CD74, SEMA4D, SEMA4B, CMTM5, NR1H2, TMEM176A, GPR55, LILRB3, MIB1, MEIS1, CTNNB1, KRAS, FCGR2B, MIXL1, C1QC]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[RBM15, SFRP2, CTNNB1, STK4]
GO:0010952;positive regulation of peptidase activity;9.0;0.7140352122741334;0.7532582313173557;9.377209824211215;435.08389316762396;4.595290077388384;0.014561866354238107;0.6312439734407735;[CYFIP2, APP, DIABLO, ROCK2, PDCD6, TRADD, ARRB1, NLRC4, TANK, BBC3, CASP9, CASP8, AIFM1, CASP10, PERP, MYC, CASP3, ARL6IP5, NLRP2, NLRP3, CTSH, MBP, RIPK1, BID, IFT57, MAP3K5, NKX3-1, PRELID1, GSN, CR1, DAPK1, BAD, RIPK2, CAV1, EIF2AK3, TNFRSF10B, TNFRSF10A, HSPE1, SIRT1, NLRP12, SFRP2, KARS, DLC1, PSME2, BAX, S100A8, PICALM]
GO:0072602;interleukin-4 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;7.9853141584524145;0.004587596526932657;0.8236103492792612;[RBPJ]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[SERPINA3, APP, ARL6IP1, PROS1, SERPINA10, WFDC1, ARRB1, PARK7, ARRB2, UBE2Z, AQP1, LAMP3, TIMP2, TIMP1, SERPINB1, CR1, CSNK2A1, SPINK8, SERPINF1, PLAUR, SERPINB9, SERPINB6, SFRP2, ADORA2A, SERPING1, BIRC6, GAPDH, NAIP, BIRC3, CSTB, CSTA, ITIH2, RNF34, IFI6, NLRC4, TFPI, THBS1, C3, BCL2L12, NLRP7, RFFL, A2M, CDKN2D, AMBP, TNFSF14, TNFRSF10B, TNFRSF10A, DHCR24, VIL1, COL7A1, MDM2, PICALM]
GO:0071874;cellular response to norepinephrine stimulus;8.0;1.0;0.875;9.628524252492122;410.2922764159275;8.67846133901236;0.01373211325256535;0.8188169164668168;[APP]
GO:0032981;mitochondrial respiratory chain complex I assembly;7.0;1.0;0.8509193652572005;9.628524252492122;91.11357555959822;5.618190544320798;0.003049489377085438;0.638233890966345;[NDUFA7, NDUFB7, NDUFA11, NDUFB10, NDUFB6, NUBPL, NDUFA10, BCS1L, TAZ, FOXRED1, NDUFS8, NDUFS7, NDUFS6, NDUFV3, NDUFAF1]
GO:2000573;positive regulation of DNA biosynthetic process;8.0;0.7980440201809971;0.7740220100904985;9.427853557029971;748.2879117532506;5.618190544320798;0.02504452299098255;0.6623145257091445;[PDGFRB, RFC5, RFC3, RFC4, XRCC5, RFC2, PNKP, ARRB2, MYC, POT1, PTK2B, CTNNB1, PRKD2]
GO:1901297;positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment;10.0;1.0;0.9152410118609203;9.628524252492122;1484.3758460528773;9.777073627680469;0.04968072371585918;0.9152410118609203;[RBPJ]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[SELP, CD4, IL6, HIST1H2BJ, IL23A, DEFB1, RNASE3, LYZ, MR1]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[CLIC5, OXTR, TFCP2L1, COMT, ADIPOR2, CRHR1, THBD, NPPA, SLC38A2, ABCC2, AMBP, IGFBP5, SPHK2, ITGA2, CAD, LNPEP, ADRA2C, BYSL, PNOC, RARA, RLN2, FOSB, KRAS, MAGED2, UPRT]
GO:0090481;pyrimidine nucleotide-sugar transmembrane transport;7.0;0.7763722522362496;0.7391054913753253;9.097896001429952;63.680604432180516;7.379178354882098;0.002131332521521897;0.728290889492758;[SLC35A2, SLC35D1, SLC35C2, SLC35B1, SLC35D2, SLC35A5]
GO:0048505;regulation of timing of cell differentiation;5.0;0.7980440201809971;0.6892630219514189;9.176539128749065;40.288675720370605;7.292166977892469;0.001348425718906689;0.6631627702307852;[RBPJ]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[OXTR, CXCL9, PKD2, PIK3CG, GPR174, GNAT2, CCR9, NPTN, ITGAV, CCR4, CCR2, GPR35, SWAP70, PRKCE, PTGER4, ITPR2, PLA2G6, P2RY8, TBXA2R, P2RY1, ABL1, CCL3, PLCG2, CHRNA10, PTK2B, CCL19, NTSR1, CCR10, TRPM4, P2RY10, GSTM2, CAV1, GPR55, ATP2B4, TPCN2, P2RX7, SLC8A3, CXCL10, CD4, P2RX5, CXCL11, P2RX4, BAX, CALM3, GHRL, CALM1, CD24, CALM2, CCL28]
GO:0006478;peptidyl-tyrosine sulfation;9.0;1.0;0.896240625180289;9.628524252492122;331.49253728226785;9.083926447120524;0.011094756898922779;0.8607930461318132;[TPST2]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[FCER1G, TFRC, TRAF6, CTNNB1, MITF, GAB2, EFNA4]
GO:0016260;selenocysteine biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;562.4022950658948;9.083926447120524;0.01882309868665063;0.8797934328124444;[SEPHS1, SEPHS2]
GO:0006906;vesicle fusion;6.0;0.6799073451904818;0.6630739851853854;8.563813515499694;63.097974703971886;5.192106149009898;0.0021118324288514666;0.5886448625081389;[STX17, STX16, GOSR2, GOSR1, STX11, RPH3A, RAB20, VPS8, VPS11, VTI1A, STX5, ANKFY1, SNAP29, SPG11, RAB8A, RAB8B, CAV2, STX7, SYT15, SYTL4, SYTL3, TAPBP, VAMP8, VPS41, VAMP1, VAMP5, STX1A, SEC22C]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[APP, NCF1, AGER, STK3, PAK1, RASSF2, DVL3, PTK2B, RIPK1, ZNF622, CCL19, MAP3K9, HRAS, SASH1, MAP3K5, MAP4K2, DBNL, SYK, FZD5, RIPK2, MAPK8IP3, ERN1, DUSP22, ZEB2, TRAF6, TAOK2, LTBR, FCGR2B, ARHGEF5, MAP3K11]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CXCL6, CXCL9, CCL3L1, CCL20, GPR35, MPL, CIB1, PPBP, CXCL5, CXCL10, CXCL11, CCL5, CCL3, CCR9, CCL2, PTK2B, CCL19, CCR4, CCR10, PF4V1, CCR2]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[ATF2, PDCD6, ITSN1, PARK7, UBE2Z, PREX1, RASSF2, PPP2R1B, RPS6KA2, MYC, ZC3H12A, ARL6IP5, IL12A, MAP3K9, HOXA5, MAP3K5, PDGFRB, PRKCI, ENDOG, FBXO18, RPS7, DAPK1, FBXW7, PRKCD, TIAM2, CLIP3, SFRP1, BRMS1, SFRP2, PPIF, PPID, S100A8, ATF4, DIABLO, PSEN1, STK4, PLA2G6, STK3, ABR, UBD, TP53BP2, NLRP2, ABL1, NLRP3, RIPK1, SUDS3, ECT2, NTSR1, TFAP2A, PRNP, PRELID1, CAV1, ZBTB16, EIF2AK3, TNFRSF10B, TNFRSF10A, EIF2S1, MLLT11, CYLD, IL6, BMP2, CDK5, NF1, SERINC3, MAP3K11, HRK, ITGB1, CD40, BTG1, YWHAB, TRADD, PTEN, PCSK9, ARRB1, ARRB2, BBC3, CASP9, ING4, FLCN, AKAP13, CASP8, AIFM1, CASP10, ADAMTSL4, C1QBP, CASP3, HYAL2, SMPD1, CASP2, CTSH, CTLA4, IFT57, RBM5, NKX3-1, ARHGEF11, IL10, KLF11, DFFA, C3orf38, ANXA1, PLEKHG2, CAMK1D, TNFRSF12A, RIPK3, PRMT2, RIPK2, ATPIF1, ITGA1, PLAUR, YWHAZ, SIRT1, SIRT2, VAV1, TGFBR1, VAV2, RHOB, DNM2, AES, SFPQ, GAL, TFDP1, LATS2, TFDP2, ADORA2A, PTRH2, TRAF6, ARHGEF1, GAPDH, ARHGEF5, ITGB3BP, ARHGEF6, CAMK2D, NLRC4, THBS1, BCLAF1, CCL5, TP53INP1, CCL3, SAP18, PLAGL2, MFN2, CCL2, ZNF622, MSX1, BID, NQO1, GSN, BIK, BAD, G0S2, HSPE1, SOD1, PPP1CA, P2RX7, NLRP12, FAP, TRIM39, DLC1, BAX, CTNNB1, MNDA, PDCD1, LTBR]
GO:0031641;regulation of myelination;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.055147161688105;6.250713103064308;0.001407547928326502;0.6427820713687392;[EIF2AK3, KIF14, PTEN, RARA, DAG1, CTNNB1, DICER1, SIRT2]
GO:0035329;hippo signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.375876246018314;8.845336528452411E-4;0.6491829203200885;[LATS2, YWHAB, CASP3, DCHS1, STK4, TEAD2, PJA2, STK3, TJP2]
GO:2000463;positive regulation of excitatory postsynaptic potential;8.0;0.9326813400603323;0.8413406700301662;9.589303539338841;397.97278468673557;6.518977089658987;0.013319790951212034;0.7083807915285978;[NLGN3, PTEN, PTK2B, STX1A, SSH1]
GO:0015732;prostaglandin transport;10.0;0.8259837884571596;0.8282329060895002;9.446202695698167;140.1325684224077;7.9853141584524145;0.004690110953974233;0.8236103492792612;[ABCC2, SLCO3A1]
